Introduction {#s1}
============

The ability of the hippocampal neurogenic niche to respond to ever-changing stimuli throughout the lifespan requires that it carefully maintain its finite stock of neural stem cells (NSCs) ([@bib41], [@bib42]). NSCs are the primary stem cells of the niche and are quite plastic in their responses: for example, social isolation seems to increase NSC self-renewal ([@bib18]), whereas running stimulates neurogenesis ([@bib70]), and seizures prompt NSCs to transform directly into reactive astrocytes ([@bib65]). Taking into account that nearly 80% of the newborn progeny of NSCs die by apoptosis ([@bib64]), the neurogenic niche needs to ensure not only that it responds properly to stimuli but also that NSCs, once they are activated, are cycling enough to produce sufficient progeny.

One way to achieve this optimization would be for the progeny to somehow communicate their status back to the ancestor NSC. Communication between 'mother' and 'daughter' cells is known to regulate lateral inhibition in the vertebral neural tube ([@bib58]) and *Drosophila* oocytes ([@bib79]), and it occurs during angiogenesis ([@bib9]) and oncogenesis ([@bib74]); in each case this communication involves Notch signaling ([@bib31]; [@bib45]; [@bib66]; [@bib69]; [@bib76]). Notch signaling is evolutionarily conserved ([@bib4]) and plays a key role in development through diverse effects on differentiation, proliferation, and survival ([@bib3]; [@bib13]; [@bib28]) that depend on signal strength ([@bib8]; [@bib16]; [@bib27]; [@bib59]; [@bib63]) and cellular context ([@bib7]; [@bib25]; [@bib49]). In the fetal brain, Notch activity maintains embryonic NSCs in an undifferentiated state ([@bib48]) by suppressing pro-neural gene expression ([@bib26]; [@bib35]; [@bib50]) and supporting progenitor survival ([@bib5]; [@bib48]). In the adult brain, Notch seems to influence quiescence, cycling, and exit of neuroprogenitors from the cell cycle, acting most likely in a cell-autonomous fashion ([@bib2]; [@bib7]; [@bib13]; [@bib20]; [@bib21]). Despite considerable advances in our understanding of Notch signaling, however, we do not know the precise cell-specific mechanism that might connect hippocampal NSCs and their progeny.

We hypothesized that, if Notch does facilitate communication between the mother NSC and its daughter cells, it might do so through the fringe proteins (Lunatic, Manic, Radical), which are known regulators of Notch signaling. Glycosylation of Notch receptors by fringe proteins affects the intracellular cleavage of the heterodimeric receptor complex and generation of the Notch1 Intra Cellular Domain (NICD) following ligand binding. Typically, NICD production increases upon binding by Delta-like (Dll) and decreases following Jagged1 (Jag1) binding ([@bib45]; [@bib66]; [@bib69]; [@bib76]); differential Notch cleavage ensures varying expression of downstream cell cycle genes ([@bib16]; [@bib36]; [@bib57]; [@bib59]; [@bib77]). To examine whether fringe proteins are present in NSCs, we systematically queried existing expression databases, such as the Allen Brain Atlas ([@bib46]) and GENSAT ([@bib29]), and discovered that Lunatic fringe (*Lfng*) appears to be selectively expressed in adult hippocampal NSCs. We confirmed this observation using *Lfng*-eGFP mice and further demonstrated the potency of *Lfng*-eGFP-expressing cells using a newly-generated *Lfng-*CreER^T2^ line for lineage tracing. The selective expression of *Lfng* in NSCs has enabled us to explicitly examine the role of Notch signaling in NSC regulation. Here, using several new transgenic mouse models, we unveil a novel Notch-based mechanism that mediates direct communication between NSCs and their progeny to control NSC quiescence and activation.

Results {#s2}
=======

*Lfng*-eGFP reporter mice specifically mark NSCs of the dentate gyrus {#s2-1}
---------------------------------------------------------------------

Our database search indicated that *Lfng* might selectively label hippocampal NSCs, prompting us to fully characterize the *Lfng*-eGFP transgenic mouse. Spatially, *Lfng*-eGFP expression in the hippocampus was restricted to the subgranular zone (SGZ) of the dentate gyrus, where neural stem and progenitor cells reside ([@bib62]) ([Figure 1A](#fig1){ref-type="fig"}, left panel). *Lfng*-eGFP^+^ cells closely resembled NSCs: their triangular soma was located in the SGZ, from which a single radial process extended orthogonally and spanned the granule cell layer, ending in fine arborizations within the molecular layer ([Figure 1A](#fig1){ref-type="fig"}, right panel). In situ hybridization for Lfng mRNA confirmed that eGFP expression recapitulated the endogenous Lfng expression pattern in the adult dentate gyrus ([Figure 1B](#fig1){ref-type="fig"}). To confirm that eGFP expression accurately reflects *Lfng* expression, we crossed *Lfng*-eGFP with *Lfng*^Tm1Grid^ mice that carry beta-galactosidase (β-Gal) insertion in the *Lfng* locus ([@bib78]). In the resulting *Lfng*^Tm1Grid^; *Lfng*-eGFP mice, β-Gal and eGFP co-localized ([Figure 1C](#fig1){ref-type="fig"}), demonstrating that the regulatory elements driving eGFP expression in *Lfng*-eGFP mice are active in the same cells that expressed β-Gal in *Lfng*^Tm1Grid^ mice. Finally, Nestin, Sox2, Vimentin, and GFAP, known to label NSCs, were all expressed in *Lfng*-eGFP^+^ cells ([Figure 1D](#fig1){ref-type="fig"}). Together, these diverse lines of evidence indicate that *Lfng*-eGFP is a marker of NSCs.10.7554/eLife.24660.002Figure 1.*Lfng*-eGFP is expressed in the NSCs of dentate gyrus.(**A**) *Left panel:* Confocal photomicrograph of the dentate gyrus in 2 month-old *Lfng*-eGFP mouse shows *Lfng*-eGFP expressing cells in the subgranular zone only. *Right panel: Lfng*-eGFP expressing cells have typical NSC morphology: triangular cell body in the subgranular zone, a single radial process spanning the granular zone, and fine terminal arborizations in the molecular layer. ML=molecular layer, GZ=granule cell zone, SGZ=subgranular zone. (**B**) In situ hybridization against the Lfng mRNA shows probe expression in the SGZ. Dotted lines indicate the borders of SGZ. (**C**) In a double transgenic *Lfng*^Tm1Grid^;*Lfng*-eGFP mouse, β-galactosidase (β--Gal) and eGFP are co-expressed, confirming that *Lfng* promoter guiding the eGFP expression is active in the same cells that express β--Gal. *Lfng*^Tm1Grid^=*Lfng*^β-Gal^ mouse that carries β-Gal insertion in the *Lfng* locus. (**D**) *Lfng*-eGFP colocalizes with other NSC markers, such as Nestin, Sox2, Vimentin, and GFAP. Confocal photomicrographs of the representative examples and relative quantitation is shown. (**E**) eGFP is briefly retained in the first progeny of NSC. *Left panel: Lfng*-eGFP expressing cell (thick arrow) and its immediate ANP progeny (arrowhead) are both BrdU^+^ and in cytoplasmic contact. BrdU^+^ ANP not in the cytoplasmic contact with the BrdU^+^ NSC has very low eGFP expression (thin arrow). *Left graph*: eGFP is cleared from BrdU^+^ ANPs between 1 to 3 days following a single dose of BrdU, corresponding to the half-life of GFP protein (N = 3--5 per group, p\<0.001 or p\<0.0001 for pairwise comparisons of all timepoints, ANOVA with Tukey post-hoc test). *Right graph: Lfng*-eGFP is expressed only in minority of Type2a ANPs (Sox2^+^ GFAP^-^ cells in the SGZ; 10.58 ± 2.38, N = 3), unlike *Nestin*-GFP (94.7 ± 0.34, N = 4). *Right panel*: Late, Tbr2^+^ ANPs (arrowheads) do not express *Lfng*-eGFP. Arrow points to *Lfng*-eGFP NSC. (**F**) *Lfng*-eGFP does not co-localize with the markers of neuronal lineage (Dcx^+^ neuroblasts and immature neurons, and NeuN^+^ granule cells) nor S100β^+^ astrocytes. (**G**) While in the *Nestin*-GFP (**N**) mice GFP is expressed in NSCs, ANPs, and other cell types throughout the dentate gyrus in approximately equal proportions (30.16 ± 2.43 NSCs, 36.12 ± 3.73 ANPs, 33.71 ± 2.81 other cell types), in the *Lfng*-eGFP (**L**) mice it is expressed predominantly in NSCs (81.68 ± 2.62% NSCs, 16.37 ± 1.54% ANPs, 1.95 ± 1.14% other cell types; N = 4 per genotype). Bars represent mean±SEM. \*\*p\<0.001, \*\*\*p\<0.0001. *Scale bars* = 100 µm (A left, (**B**), 20 µm (A right, (**C--F**). See [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"} for further details.**DOI:** [http://dx.doi.org/10.7554/eLife.24660.002](10.7554/eLife.24660.002)10.7554/eLife.24660.003Figure 1---figure supplement 1.*Lfng*-eGFP labels a small number of non-NSC cell types in the dentate gyrus. (**A**) In a double transgenic *Lfng*-eGFP; *Nestin*-CFP^nuc^ mouse, NSCs express both CFP and eGFP, and have a radial GFAP^+^ process (arrow). Those that express only CFP have round morphology with no processes and are presumed ANPs (arrowheads). Orthogonal projection shows a NSC expressing both *Lfng-*eGFP and *Nestin*-CFP^nuc^ (black arrowhead) and a neighboring ANP expressing only *Nestin*-CFP^nuc^ (white arrowhead). *Scale bar* = 20 µm. (**B**) *Lfng*-eGFP is expressed in tip-like cells in close proximity to the endothelial cells immunolabeled with CD31 (arrowhead). *Scale bar* = 20 µm. (**C**) Random unidentified *Lfng*-eGFP^+^ cells are detected in the hilus (left panel; arrowhead) and molecular layer (right panel; arrowhead). *Scale bar* = 20 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.24660.003](10.7554/eLife.24660.003)

A small proportion of the eGFP-expressing cells in the SGZ had a round amplifying neuroprogenitors (ANP) -like morphology with no associated processes. To determine whether ANPs express eGFP, we crossed *Lfng*-eGFP with the *Nestin*-CFP^nuc^ mice, which express CFP in the nuclei of both NSCs and ANPs ([@bib24]). In the double transgenic mice, all *Lfng*-eGFP^+^ cells co-expressed CFP ([Figure 1---figure supplement 1A](#fig1s1){ref-type="fig"}), but only 7.4 ± 1.9% (mean ± SEM, N = 3) of the CFP-labeled ANPs contained eGFP. The eGFP^+^ ANPs were in close proximity to dividing BrdU^+^ NSCs and in all cases were in cytoplasmic connection with the mother NSC ([Figure 1E](#fig1){ref-type="fig"}, left panel), which suggests that the asymmetric division had not yet finished. ANPs not cytoplasmically connected with the NSCs had little if any eGFP ([Figure 1E](#fig1){ref-type="fig"}, left panel).

We next examined how long it took newborn ANPs to clear eGFP, using BrdU pulse-and-chase labeling. eGFP was cleared from *Lfng*-eGFP^+^ ANPs, but not from *Nestin*-GFP^+^ ([@bib53]) ANPs, between days 1 and 3 ([Figure 1E](#fig1){ref-type="fig"}, left graph). The clearance correlates with the half-life of GFP ([@bib17]), suggesting that the eGFP in ANPs is likely from the protein retained by the first progeny of *Lfng*-eGFP^+^ NSCs. Indeed, only 10% of Type 2a cells (Sox2^+^ early ANPs) were eGFP^+^ in *Lfng*-eGFP mice compared to almost 95% in *Nestin*-GFP mice ([Figure 1E](#fig1){ref-type="fig"}, right graph). No Type 2b cells (late ANPs) expressed *Lfng*-eGFP ([Figure 1E](#fig1){ref-type="fig"}, right panel). Together, these data strongly suggest that most of the *Lfng*-eGFP^+^ ANPs are the immediate progeny of NSCs that retained some eGFP due to sequestration of the protein during cell division. ANPs quickly lose eGFP, implying that *Lfng*-eGFP expression is selective for NSCs and that *Lfng* is active in NSCs but not in ANPs.

*Lfng*-eGFP was not detected in neuroblasts/immature neurons, granule cells, or astrocytes ([Figure 1F](#fig1){ref-type="fig"}). In a minority of cases (0.8%) we observed the endothelial cell marker CD31 overlapping with *Lfng*-eGFP ([Figure 1---figure supplement 1B](#fig1s1){ref-type="fig"}). This is not surprising, as endothelial tip cells express Lfng during tip-stalk cell selection after exposure to angiogenic factors ([@bib9]). Further, we observed a few *Lfng*-eGFP^+^ cells, some co-labeled with GFAP^+^ or S100β^+^, randomly distributed in the dentate gyrus (0.9%; [Figure 1---figure supplement 1C](#fig1s1){ref-type="fig"}). The overall quantification of the cell-type expression of eGFP indicated that the majority of eGFP^+^ cells in *Lfng*-eGFP mice were NSCs (81.7 ± 2.6%), while only 16.4 ± 1.5% were ANPs and 1.9 ± 1.1% were other cell types ([Figure 1G](#fig1){ref-type="fig"}). In contrast, in *Nestin*-GFP mice, the majority of GFP^+^ cells were ANPs (36.1 ± 3.7%), followed by other cell types (33.7 ± 2.8%) and NSCs (30.2 ± 2.4%). These data emphasize the specificity of *Lfng*-eGFP expression for adult hippocampal NSCs, compared to the low selectivity of *Nestin*-GFP expression for NSCs.

At any given time, the majority of NSCs is quiescent; only about 1--4% of them divide under physiological conditions ([@bib23]; [@bib39]). This property enables them to escape treatment with cytostatic drugs, such as temozolomide ([@bib39]). Indeed, only 15.0 ± 3.0% of the eGFP^+^ cells were lost in *Lfng*-eGFP mice following temozolomide treatment (N = 4, p=0.27), compared to 35.0 ± 4.0% in the *Nestin*-GFP mice (N = 4, p=0.0035). This suggests that the *Lfng*-eGFP^+^ population consists mostly of quiescent NSCs, which we confirmed by independent quantification of NSCs and ANPs ([Figure 2A](#fig2){ref-type="fig"}). Further, if *Lfng*-eGFP^+^ cells are true NSCs, then both physical exercise and electroconvulsive shock (ECS) should activate them ([@bib49]; [@bib52]; [@bib60]; [@bib67]; [@bib70], [@bib71]; [@bib72]). We therefore tested whether *Lfng*-eGFP^+^ NSCs respond to these stimuli. Mice were either administered a single ECS for four consecutive days or subjected to voluntary access to a running wheel for a week, followed by a single injection of BrdU. Sham controls either did not receive ECS or had a locked running wheel in their cage. Mice were sacrificed 24 hr after the BrdU injection and the BrdU^+^ NSCs were quantified. A robust increase in the percentage of BrdU^+^ *Lfng*-eGFP^+^ NSCs in both conditions (N = 4 per group in ECS, p=0.0006; and N = 6 per group in PE, p=0.0271) indicated that *Lfng*-eGFP^+^ NSCs are plastic, as expected ([Figure 2B](#fig2){ref-type="fig"}).10.7554/eLife.24660.004Figure 2.*Lfng*-eGFP-expressing cells are functional NSCs.(**A**) Most *Lfng*-eGFP^+^ NSCs are quiescent. Bar graphs represent the total number of GFP^+^ cells (left panel), GFP^+^ NSCs (middle panel) and GFP^+^ ANPs (right panel) in 3 month-old *Nestin*-GFP and *Lfng*-eGFP mice (N = 4 per genotype) treated with temozolomide (TMZ). The difference between the two mouse models is most notable with respect to ANPs: while *Nestin*-GFP labels a large number of ANPs, *Lfng*-eGFP does not - it labels primarily quiescent cells. (**B**) Electroconvulsive shock (ECS) and physical exercise (PE) both activate *Lfng*-eGFP^+^ NSCs (N = 4 per group in ECS and N = 6 per group in PE). (**C**) *Lfng*-eGFP NSCs produce neuronal progeny. The relative number of newborn, BrdU^+^ progeny was quantified over a 30 day period (NSCs: *Nestin*-GFP^+^ or *Lfng*-eGFP^+^ cells with GFAP^+^ radial processes; ANPs: GFAP^-^ Dcx^-^ NeuN^-^; NBs: Dcx^+^ neuroblasts and immature neurons; GCs: NeuN^+^; Other: BrdU^+^ Dcx^-^ NeuN^-^ cells outside the SGZ; N = 4 per genotype per timepoint). Cumulative BrdU paradigm (four 150 mg/kg injections given 2 hr apart) was used to increase the yield of labeled newborn cells. N=*Nestin*-GFP mice, L=*Lfng*-eGFP mice. (**D**) The number of *Lfng-*eGFP^+^ NSCs declines over an 18 month period comparably to the number of *Nestin*-GFP^+^ NSCs (left panel; N = 4 per timepoint per genotype). However, the contribution of GFP^+^ cell types in the *Nestin*-GFP and *Lfng-*eGFP mice differs at different age (right panel). While *Lfng-*eGFP remains selective for NSCs during aging (p\>0.15 for all timepoints, Tukey post-hoc test), *Nestin*-GFP labels significantly more non-neuroprogenitors in older mice (p\<0.002; Tukey post-hoc test). Bars represent mean±SEM. NS=non-significant, \*p\<0.05, \*\*p\<0.001. See [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"} for further details.**DOI:** [http://dx.doi.org/10.7554/eLife.24660.004](10.7554/eLife.24660.004)10.7554/eLife.24660.005Figure 2---figure supplement 1.The specificity of *Lfng*-eGFP expression for NSCs does not change over time.(**A**) The total number of BrdU^+^ cells (NSCs and their progeny) in *Nestin*-GFP and *Lfng*- eGFP mice over a 30 day period indicates that cell survival is similar in both mouse models. (**B**) Neither the total number BrdU^+^ cells (*left panel*) nor the relative number of BrdU^+^ NSCs (*right panel*) in *Nestin*-GFP and *Lfng-*eGFP mice significantly differs over the 18 month period investigated (N = 4 per genotype per timepoint), indicating that the proliferative capacity of NSCs in the two mouse models is similar. (**C**) Confocal photomicrographs are representative examples of the dentate gyri of *Nestin*-GFP and *Lfng-*eGFP mice at a given age. Note a decline in the number of GFP^+^ NSCs in both models. However, while the GFP^+^ non-progenitors ('other cells') prevail as the *Nestin*-GFP mice age, in the *Lfng-*eGFP mice eGFP remains expressed in NSCs and the contribution of the GFP^+^'other cells' is minimal. See [Figure 2D](#fig2){ref-type="fig"} for quantification. Bars represent mean ± SEM. *Scale bar* = 20 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.24660.005](10.7554/eLife.24660.005)

We next assessed the net outcome of neurogenesis using BrdU pulse-and-chase labeling and compared *Lfng*-eGFP and *Nestin*-GFP mice to determine whether there were any gross differences in these two different transgenic lines. Over the course of 30 days, the total number of BrdU^+^ cells in the dentate gyrus followed the same pattern of decline (R = 0.9992; [Figure 2---figure supplement 1A](#fig2s1){ref-type="fig"}). The decay was rapid between 1 and 3 days post-BrdU injection (dpi; 100--105 BrdU^+^ cells lost per hour), slowed to 31--27 BrdU^+^ cells/hr between 3 and 7dpi, and reached a stable rate of 3--4 BrdU^+^ cells/hr between 7-15dpi, and 2--3 cells/hr between 15 and 30dpi. Neurogenesis in *Lfng*-eGFP mice thus follows the same survival pattern observed in *Nestin*-GFP mice ([@bib37]; [@bib40]; [@bib64]). Further, the *Lfng*-eGFP^+^ NSCs produced the same neurogenic progeny as *Nestin*-GFP^+^ NSCs over 30 days, providing further assurance that there are no gross differences in these two transgenic lines ([Figure 2C](#fig2){ref-type="fig"}). This is important, because it establishes the benchmark validity of the *Lfng*-eGFP mice for studies of neurogenesis.

Finally, adult neurogenesis declines with age ([@bib42]), at least in part because of a decline in the NSC population ([@bib23]). Thus, if *Lfng*-eGFP^+^ cells are NSCs, then their number should decrease over time. This is, in fact, what we observed; over an 18 month period the number of NSCs ([Figure 2D](#fig2){ref-type="fig"}, left panel), the number of BrdU^+^ cells ([Figure 2---figure supplement 1B](#fig2s1){ref-type="fig"}, left panel) and the proportion of BrdU^+^ NSCs ([Figure 2---figure supplement 1B](#fig2s1){ref-type="fig"}, right panel) were similar between the *Lfng*-eGFP and *Nestin*-GFP mice. Unlike the *Nestin*-GFP mice, however, the specificity of *Lfng*-eGFP expression for NSCs did not change over time ([Figure 2D](#fig2){ref-type="fig"}, right panel; [Figure 2---figure supplement 1C](#fig2s1){ref-type="fig"}). This is a crucial finding because it signifies the utility of the *Lfng*-eGFP mouse model for specific studies of NSC biology during aging.

Lfng-expressing NSCs generate diverse progeny {#s2-2}
---------------------------------------------

The claim that *Lfng*-eGFP^+^ cells are functional NSCs capable of producing diverse progeny requires lineage tracing. Thus, we generated a *Lfng*-CreER^T2^ transgenic line using the same bacterial artificial chromosome used to generate *Lfng*-eGFP mice, modified by inserting CreER^T2^ in front of the transcription start site of the *Lfng* (RP23-270N2; [Figure 3A](#fig3){ref-type="fig"}). To verify that CreER^T2^ is selectively expressed in NSCs, we bred *Lfng-*CreER^T2^ mice to the AI14 (RCL-tdT) reporter line (Jackson Lab Stock no: 007908) ([@bib51]) and then to *Lfng*-eGFP mice. One day following induction, 89.1 ± 4.0% of tdTomato^+^ cells were eGFP^+^ and 37.9 ± 1.5% of *Lfng*-eGFP^+^ NSCs were tdTomato^+^ ([Figure 3B](#fig3){ref-type="fig"}). No tdTomato expression was observed after vehicle administration ([Figure 3---figure supplement 1A](#fig3s1){ref-type="fig"}).10.7554/eLife.24660.006Figure 3.Lfng-expressing NSCs generate diverse progeny.(**A**) The map of bacterial artificial chromosome (BAC) construct used to generate the *Lfng-*CreER^T2^ mouse. (**B**) In *Lfng-*CreER^T2^; RCL-tdT; *Lfng-*eGFP triple transgenic mouse, tdTomato^+^ and eGFP^+^ co-expressing cells demonstrate the specificity of the *Lfng-*CreER^T2^ line to NSCs. *Left panel:* Confocal photomicrograph of the dentate gyrus of a 6 month-old mouse shows the overlapping expression of eGFP and CreER^T2^-controlled tdTomato one day following tamoxifen injection (TMX; 120 mg/kg). *Right panel:* Quantification of the co-expression of tdTomato^+^ and eGFP^+^ in induced *Lfng-*CreER^T2^; RCL-tdT mice (N = 3). Bars represent mean±SEM. (**C**) TMX-induced cells have NSC morphology and divide both asymmetrically and symmetrically. *Left panel*: tdTomato^+^ NSC co-expresses GFAP and Sox2. *Middle panel*: tdTomato^+^ NSC (arrow) divides asymmetrically to produce ANP (arrowhead). *Right panel*: NSC divides symmetrically to produce two cells (arrows) with prominent GFAP^+^ radial processes. *Scale bars* = 20 µm. (**D**) tdTomato^+^ NSCs produce new neurons through established cascade of cell types, from Tbr2^+^ late ANPs (Type 2b cells), through Dcx^+^ immature neurons, to NeuN^+^ granule cells. *Scale bars* = 20 µm. (**E**) tdTomato^+^ NSCs also produce S100β astrocytes (or astrocyte-like cells) within the granule cell layer (*left panel*), as well as stellar Sox2^+^ GFAP^+^ cells in the hilus (*right panel*) *Scale bars* = 20 µm. (**F**) Fate mapping of tdTomato^+^ cells following TMX induction in *Lfng-*CreER^T2^; RCL-tdT mice reveals that NSCs form the majority (85.7% ± 0.9) of the induced cells at 1dpi, but progressively decline in ratio as they give rise to different progeny over the course of 2 months (N = 3--5 per timepoint). See [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"} for further details.**DOI:** [http://dx.doi.org/10.7554/eLife.24660.006](10.7554/eLife.24660.006)10.7554/eLife.24660.007Figure 3---figure supplement 1.*Lfng*-CreER^T2^ expressing cells are NSCs giving rise to newborn neurons. (**A**) tdTomato expression in *Lfng-*CreER^T2^; RCL-tdT animals 3 months following vehicle treatment. No tdTomato is observed, indicating no leakage. Scale bar = 50 µm. (**B**) Both the number of NSCs (N = 4, p=0.039) and the number of cycling Ki67^+^ cells (N = 4, p\<0.0001) significantly decline following diphtheria toxin (DTX) injection in *Lfng-*CreER^T2^; *iDTR* mice, further confirming the stemness of Lfng-expressing NSCs. DTR expression in *Lfng-*CreER^T2^; *iDTR* mice was induced by tamoxifen (TMX (day 0), followed by four injections of DTX (16 µg/kg) two days apart to kill *Lfng-*CreER^T2^ derivatives. Mice were sacrificed at 15 days post-induction. (**C**) A confocal photomicrograph of a newborn neuron with prominent dendritic spines and axonal projections to CA3 region, observed at 30 days post-induction in *Lfng-*CreER^T2^; RCL-tdT. *Scale bar* = 100 μm. (**D**) Occasionally, tdTomato^+^ tip cells were observed following induction in *Lfng-*CreER^T2^; RCL-tdT mice. *Scale bar* = 20 μm.**DOI:** [http://dx.doi.org/10.7554/eLife.24660.007](10.7554/eLife.24660.007)

To further verify that Lfng-expressing NSCs are dividing, we crossed the *Lfng*-CreER^T2^ mice with the *iDTR* mice, in which the diphtheria toxin receptor (DTR, a.k.a. Hbegf, simian Heparin-binding epidermal growth factor-like growth factor) is conditionally expressed under the control of Cre-activated Rosa26 locus ([@bib14]). Activation of this receptor by diphtheria toxin selectively kills DTR-expressing cells ([@bib14]). Fifteen days following induction of DTR in *Lfng*-CreER^T2^; *iDTR* mice and activation by diphtheria toxin, we observed a significant reduction in both NSCs (36.8 ± 1.5%; N = 3--4 per group; p=0.0244) and the Ki67^+^ cells (57.3 ± 2.4%; p\<0.0001) ([Figure 3---figure supplement 1B](#fig3s1){ref-type="fig"}). As neither DTR expression nor the high dose of diphtheria toxin alone cause cell death ([@bib6]; [@bib14]; [@bib30]), our data confirm the proliferative properties of Lfng-expressing NSCs and indicate that even partial elimination of NSCs leads to a dramatic decrease of cycling cells in the SGZ neurogenic niche.

Next, we examined the lineage of tdTomato^+^ NSCs in *Lfng-*CreER^T2^;RCL-tdT mice ([Figure 3C--E](#fig3){ref-type="fig"} and [Figure 3---figure supplement 1C,D](#fig3s1){ref-type="fig"}). We first focused on NSCs and their immediate progeny. Within 1--2 days after a single dose of tamoxifen (200 mg/kg), induced NSCs with radial processes and fine arborizations in the molecular layer appeared as tdTomato^+^ cells. They expressed Sox2 and GFAP, further supporting recombination in NSCs ([Figure 3C](#fig3){ref-type="fig"}, left panel). They divided both asymmetrically, to give rise to ANPs ([Figure 3C](#fig3){ref-type="fig"}, middle panel) and symmetrically, to give rise to two Sox2^+^ cells connected via cytoplasm and both having prominent GFAP^+^ radial processes ([Figure 3C](#fig3){ref-type="fig"}, right panel). We then performed fate-mapping for two months, using a lower dose (120 mg/kg) of tamoxifen to sparsely induce cells and allow visualization of progeny morphology. Within 3 days of induction we detected tdTomato^+^ Tbr2^+^ late ANPs (Type 2b cells), followed by Dcx^+^ immature neurons 7 days after ([Figure 3D](#fig3){ref-type="fig"}). Thirty days following induction, tdTomato^+^ cells expressed the granule cell marker NeuN ([Figure 3D](#fig3){ref-type="fig"}) and had extended processes reaching the molecular layer, prominent dendritic spines, and an axon extending throughout the hilus to the CA3 region ([Figure 3---figure supplement 1C](#fig3s1){ref-type="fig"}). These data demonstrate that Lfng-expressing cells generate neurons and enable detailed studies of the neuronal lineage linked directly to a single NSC.

In addition to neuronal progeny, we also detected tdTomato^+^ S100β^+^ astrocytes in the granule cell layer ([Figure 3E](#fig3){ref-type="fig"}, left panel) and tdTomato^+^ Sox2^+^ GFAP^+^ astrocyte-like cells in the hilus ([Figure 3E](#fig3){ref-type="fig"}, right panel). These may represent either terminally differentiated NSCs or the progeny of *Lfng*-expressing NSCs; characterization of these cells is beyond the scope of this paper and will await future studies. Finally, as in the *Lfng*-eGFP mice, we found tdTomato^+^ tip cells in *Lfng*-CreER^T2^; RCL-tdT mice ([Figure 3---figure supplement 1D](#fig3s1){ref-type="fig"}), further supporting the finding that the same regulatory elements control the expression of both eGFP and CreER^T2^ in these two different mouse models.

Quantitative evaluation of the lineage of Lfng-expressing NSCs provided additional information on the progeny and differentiation timeline ([Figure 3F](#fig3){ref-type="fig"}). Initially, most of the population consisted of NSCs with some ANPs and astrocyte-like cells (GFAP^+^, S100β^-^). Over the course of 60 days, the contribution of NSCs to the population of tdTomato^+^ cells diminished because of the growing contribution of ANPs, immature neurons and granule cells. Interestingly, the population of ANPs and immature neurons remained stable from 15 days on, indicating a continuous replenishment of these cell types. The granule cell number steadily increased from 15 days on and represented about 30% of all tdTomato^+^ cells at 60 days following induction. Surprisingly, the number of astrocyte-like cells did not change over the course of 60 days, although there was one change: these cells were mostly GFAP^+^, S100β^-^ between 1 and 15 days and mostly GFAP^+^, S100β^+^ thereafter. It may be that there is a steady conversion of NSCs into astrocyte-like cells that is independent of neurogenesis. Finally, we occasionally detected other tdTomato^+^ cell types (mostly tip cells and their descendant endothelial cells), which constituted 6.8 ± 1.8% of the population at 60 days. In summary, these data demonstrate that Lfng-expressing cells in the SGZ are NSCs, able to self-renew and produce both neuronal (majority) and astrocytic (minority) lineage in the adult dentate gyrus. Collectively, these data establish *Lfng*-eGFP and *Lfng*-CreER^T2^ as novel mouse models enhancing the existing repertoire of tools ([@bib61]). With these new mouse models, the field will be able to study the intrinsic properties of NSCs distinct from their progeny and gain a deeper understanding of the mechanisms of quiescence and lineage potential in the healthy brain, during aging, and in disease.

Notch pathway elements are present in the SGZ NSC niche {#s2-3}
-------------------------------------------------------

The selective expression of *Lfng* in adult SGZ NSCs raises the question about its functional role in these cells. Surprisingly, the biological role of *Lfng* in adult SGZ NSCs has never been examined, despite its known function as a direct transcriptional target of Notch ([@bib55]) and the importance of Notch signaling for adult NSC maintenance ([@bib2]; [@bib13]; [@bib20]; [@bib28]). Lfng N-glycosylates Notch receptors ([@bib54]), affecting the intracellular cleavage of the heterodimeric receptor complex and generation of the NICD following ligand binding: typically, Lfng modification of Notch elevates NICD production upon Dll1 binding, but decreases it following engagement to Jag1 ([@bib31]; [@bib45]; [@bib66]; [@bib69]; [@bib76]). This might lead to differential activation of cell cycle genes downstream of Notch, depending on which type of ligand dominates ([@bib16]; [@bib36]; [@bib57]; [@bib59]; [@bib63]; [@bib77]).

In agreement with published data ([@bib13]; [@bib43]), we found the key elements of the Notch pathway expressed in the NSCs and surrounding progeny: Notch1 on the surface of NSCs, Jag1 on presumed ANPs surrounding NSCs, and Dll1 on granule neurons neighboring the apical parts of the NSC soma ([Figure 4A](#fig4){ref-type="fig"}). In addition, Hes5 (an indicator of canonical Notch pathway; [@bib34]; [@bib49]) was present in some but not all *Lfng*-eGFP^+^ NSCs ([Figure 4A](#fig4){ref-type="fig"}).10.7554/eLife.24660.008Figure 4.Notch pathway elements are present in the SGZ NSC niche.(**A**) Notch1 is expressed in *Lfng*-eGFP NSCs, facing granule cell layer, where late ANPs (type 2b cells) and granule cells are located. Jag1 is expressed in adjacent ANP, and Dll1 on adjacent granule cell-NSC boundary. Hes5, downstream target of canonical Notch signaling pathway, is present in some (arrowhead) but not all (empty arrowhead) NSCs. *Scale bar* = 10 µm (Notch1, Jag1, Dll1); 20 µm (Hes5). (**B**) Venus is expressed in some (arrowhead) but not all (empty arrowhead) NSCs (Sox2+ cell body and GFAP+ process) in CBF:H2B-Venus mice. Type 2b cells (Tbr2) and most of the neuroblasts and immature neurons are Venus -, whereas almost all granule cells (NeuN^+^) are Venus+ with various degrees of intensity. Some of the mature astrocytes (S100β^+^) have active Notch signaling (arrowheads). Quantification of Venus signal among various cell types reveals that most of the differentiating cells are devoid of active Notch signaling. As soon as the neurogenic differentiation finishes, Notch signaling is turned on again in the granule cells. *Scale bar* = 10 µm upper panels and 20 µm middle and lower panels. (**C**) NICD1 and Venus colocalize in CBF:H2B-Venus mice. NICD1 almost completely overlaps with the Venus signal in the SGZ (left inset), while it is lacking in the molecular layer (right inset). *Scale bar* = 20 µm. Quantification of Venus^+^ cells among NICD1^+^ cells in GZ and SGZ verifies high degree of colocalization (N = 3; 90.79 ± 0.77% and 96.95 ± 0.57%, respectively).**DOI:** [http://dx.doi.org/10.7554/eLife.24660.008](10.7554/eLife.24660.008)

We further examined Notch signaling in NSCs using CBF:H2B-Venus (JAX 020942) ([@bib19]), a Notch reporter mouse in which YFP variant Venus is expressed under the control of CBF1 promoter. Approximately half of the NSCs had active Venus^+^ Notch signaling at any given time, whereas Venus expression declined in early (Sox2^+^) and late (Tbr2^+^) ANPs as well as in neuroblasts and immature neurons (Dcx^+^) ([Figure 4B](#fig4){ref-type="fig"}). Notch signaling was turned on again in mature granule neurons as most of the NeuN^+^ cells were positive for Venus signal with various degrees of intensity ([Figure 4B](#fig4){ref-type="fig"}), in agreement with the previous reports ([@bib12]; [@bib13]).

Although CBF:H2B-Venus mice are a good tool to evaluate the presence or absence of Notch signaling, the accumulation of Venus fluorescence protein and high fluorescence intensity in the GZ ([Figure 4B](#fig4){ref-type="fig"}) make it hard to perform reliable intensity quantifications in the SGZ where NSCs reside. We therefore turned to NICD1 as a more reliable measure of Notch signaling intensity. To verify the reliability of NICD1 staining, we reasoned that NICD1 should be present in cells expressing Venus. Indeed, the NICD1 expression overlapped with Venus expression in CBF:H2B-Venus mice: over 90% in SGZ and over 95% in GZ ([Figure 4C](#fig4){ref-type="fig"}).

These expression data provide the foundation for our hypothesis that Notch signaling, mediated by Lfng, represents a mode of communication between the progeny and the NSC to preserve the ancestor cell. Namely, in the resting state, the Dll1-expressing granule cells surrounding the NSC would promote NSC quiescence, so only a few stimulated NSCs would undergo division rather than the whole population. Once the NSC starts to divide in response to a given stimulus, the local accumulation of the Jag1-expressing ANP progeny would gradually shift the balance of Notch signaling within the 'mother' NSC, eventually halting Notch signaling and leading the NSC to exit the cell cycle. This would be beneficial on two fronts: it would prevent the niche from becoming overwhelmed by the perpetual production of ANPs, and it would preserve the mother NSC from exhaustion as there is only a finite number of divisions it can endure.

Lfng preserves NSCs by controlling their cell cycle {#s2-4}
---------------------------------------------------

We first postulated that *Lfng* functions to preserve NSCs in both resting and active states, saving them from excessive mitosis. If this is the case, then lack of *Lfng* would lead to increased NSC division and their premature depletion from the niche. To examine the effect of *Lfng* ablation on NSC maintenance, we obtained *Lfng*^tm1Grid^ mice (*Lfng*^−/+^; JAX 010619), in which most of the exon1 region of the *Lfng* is replaced by a targeting vector containing *β-gal* ([@bib78]). Mice heterozygous for *Lfng* mutation are grossly normal. Homozygote mice typically have shortened trunks and malformed rib cages that impair respiration and cause premature death; the phenotype is variable, however, and some less severely affected homozygous mice do survive to adulthood ([@bib78]). Because we could not consistently mate *Lfng*^−/+^ with *Lfng*-eGFP mice, we first developed a reliable method to quantify NSCs in the absence of eGFP reporter. We used a combination of markers known to be expressed in NSCs: Sox2 for labeling the NSC cell body ([@bib67]) and GFAP for labeling the NSC radial process ([@bib22]). We compared the NSC number in wild-type mice (using GFAP/Sox2 immunostainings) and *Lfng*-eGFP mice (using eGFP expression, GFAP^+^ radial process and cell morphology) and found no significant difference between the two methods (N = 3; p=0.99; [Figure 5A](#fig5){ref-type="fig"}). Thus, for all subsequent studies where NSCs could not be identified because of the lack of fluorescent reporter, we used the GFAP/Sox2-based identification.10.7554/eLife.24660.009Figure 5.Lfng preserves NSCs by controlling their cell cycle.(**A**) *Left panel: Lfng-*eGFP NSCs express GFAP^+^ radial processes originating from the Sox2^+^ cell nuclei located in the SGZ. *Right panel*: The total number of GFAP^+^ Sox2^+^ NSCs in 4-month-old wild-type mice does not differ from the total number of eGFP^+^ NSCs in 4 month-old *Lfng-*eGFP (N = 3 per group; Student's *t*-test, p=0.99). *Scale bar* = 10 µm. (**B**) The total number of NSCs in 2-month-old wild-type, *Lfng* heterozygote (*Lfng*^−/+^), and homozygote (*Lfng*^−/−^) knockout mice shows *Lfng* dose-dependent decrease in the NSC population (N = 3--4 per group; One-way ANOVA p\<0.00001, Tukey HSD post-hoc test: p\<0.0001 for wild-type vs *Lfng*^−/+^ or *Lfng*^−/−^, p=0.0484 for *Lfng*^−/+^ vs *Lfng*^−/−^). (**C**) Lack of *Lfng* promotes increased division of NSCs. *Left panel*: NSCs lacking *Lfng* have a higher ratio of cycling Ki67^+^ NSCs compared to wild-type (N = 4 per group; Student's *t*-test p=0.0221). *Middle panel*: NSCs lacking *Lfng* have a higher ratio of actively dividing, BrdU^+^ NSCs compared to wild-type (N = 4 per group; Student's *t*-test p=0.0017). *Right panel*: *Lfng* acts cell-autonomously and in a dose-dependent manner to control the NSC division (N = 4 per group). The ratio of BrdU^+^ NSCs was compared between i*Lfng*^fl/fl^ mutant clones (tdTomato^+^), i*Lfng*^fl/fl^ wild type clones (tdTomato^-^ GFAP^+^ Sox2^+^), and *Lfng-*CreER^T2^; RCL-tdT control mice (tdTomato^+^ GFAP^+^ Sox2^+^). N = 4; p=0.9978 for control vs i*Lfng*^fl/fl^ tdTom^-^ clones; p=0.0049 for control vs i*Lfng*^fl/fl^ tdTom^+^ clones; p=0.0045 for i*Lfng*^fl/fl^ tdTom^-^ clones vs i*Lfng*^fl/fl^ tdTom^+^ clones. (**D**) NSCs lacking *Lfng* are hyper-activated in response to ECS treatment (N = 3--4 per group; Student's *t*-test, p=0.0178). (**E**) Lack of *Lfng* decreases Notch signal intensity in mutant NSCs. Relative intensities of NICD1 staining are significantly lower in i*Lfng*^fl/fl^ mutant NSCs compared to control (N = 4 for control; N = 3 for i*Lfng*^fl/fl^; Student's t-test, p=0.0004). (**F**) NSCs lacking *Lfng* spend less time in the active state than wild-type NSCs. *Lfng* absence is associated with decreased S-phase re-entry 3 (*left panel*) and 7 (*middle panel*) days following the initial division compared to the wild-type NSCs (N = 4 per group; Student's *t*-test, p=0.0024 for 3d, p=0.0003 for 7d). CldU^+^ IdU^+^ cells represent NSCs that underwent first division at the time of CldU injection (day 0) and were in S-phase at the time of IdU injection (day 3 or day 7). *Right panel:* In i*Lfng*^fl/fl^ mice, no NSCs were found that re-entered S-phase 7 days after the initial division. CldU^+^ IdU^+^ cells represent NSCs that were induced at day 0, underwent first division 1 day post-induction (CldU^+^) and were in S-phase 7 days post-induction (IdU^+^; N = 3--4 per group; Student's *t*-test, p=0.0014). (**G**) NSCs lacking *Lfng* mostly exit cell cycle within a week of first division. CldU^+^ Ki67^+^ NSCs represent NSCs that are actively cycling 7 days following the CldU injection (N = 4; Student's *t*-test, p=0.0105). (**H**) NSCs lacking *Lfng* give rise to astrocyte-like cells. *Left panel*: The number of BrdU-retaining NSCs 7 days after the BrdU injection is significantly reduced in *Lfng*^−/+^ mice compared to wild-type (N = 4 per timepoint; Student's *t*-test, p=0.0003). *Middle panel*: In i*Lfng*^fl/fl^ mice, significantly more tdTomato^+^ astrocyte-like cells accumulate 7 and 30 days following induction compared to controls, while the number of tdTomato^+^ ANPs significantly decreases (N = 4 per group, p=0.0003 and p\<0.0001 for astrocyte-like cells, p=0.0024 and p=0.0049 for ANPs). *Right panel*: The number of BrdU-retaining astrocyte-like cells 7 days after the BrdU injection is significantly higher in i*Lfng*^fl/fl^ mice compared to controls, but the difference is lost at 30 days (N = 4 per group; Student's *t*-test, p=0.0302 for 7 days, p=0.4412 for 30 days). Bars represent mean ± SEM. \*p\<0.05, \*\*p\<0.001, \*\*\*p\<0.0001. See [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"} for further details.**DOI:** [http://dx.doi.org/10.7554/eLife.24660.009](10.7554/eLife.24660.009)10.7554/eLife.24660.010Figure 5---figure supplement 1.*Jag1* and *Lfng* affect cell survival in the SGZ.(**A**) ApopTag immunostaining in control, i*Lfng*^fl/fl^, and i*Jag1*^fl/fl^ mice. Regions outlined in left images are presented in high magnification on the right. *Scale bars* = 100 µm (low magnification); 20 µm (high magnification). (**B**) Cell death is significantly decreased in i*Lfng*^fl/fl^ and i*Jag1*^fl/fl^ SGZ in comparison to control both by ApopTag^-^based (left) and activated caspase 3 (act-casp3)-based (right) detection methods. The average number of ApopTag or act-casp3+ cells in control mice was used for normalization (N = 3 per group; One-way ANOVA p\<0.00001, Tukey HSD post-hoc test: i) ApopTag: p=0.006 for control vs i*Lfng*^fl/fl^, p=0.0375 for i*Lfng*^fl/fl^ vs i*Jag1*^fl/fl^, p\<0.00001 for control vs i*Jag1*^fl/fl^; ii) act-casp3: p=0.0089 for control vs i*Lfng*^fl/fl^, p=0.9261 for i*Lfng*^fl/fl^ vs i*Jag1*^fl/fl^, p=0.0224 for control vs i*Jag1*^fl/fl^). Bars represent mean ± SEM. \*p\<0.05, \*\*p\<0.001.**DOI:** [http://dx.doi.org/10.7554/eLife.24660.010](10.7554/eLife.24660.010)

Mice lacking *Lfng* had markedly fewer NSCs than wild-type mice ([Figure 5B](#fig5){ref-type="fig"}). This reduction in NSC number could be due to changes in the NSC cell cycle ([@bib2]; [@bib13]; [@bib20]; [@bib28]), as it has been suggested that NSCs undergo a finite number of divisions followed by their transformation into astrocyte-like cells ([@bib23]). We examined the ratio of cycling Ki67^+^ NSCs and BrdU^+^ NSCs in mutant and wild-type mice and found that NSCs lacking *Lfng* were both cycling ([Figure 5C](#fig5){ref-type="fig"}, left panel) and in S-phase ([Figure 5C](#fig5){ref-type="fig"}, middle panel) in significantly higher proportions than wild-type NSCs (N = 4; p=0.0221 for Ki67^+^ NSCs; p=0.0017 for BrdU^+^ NSCs).

Because these data were obtained in constitutive knockout mice, however, it is possible that they do not reflect the direct effect of *Lfng*. Therefore, to specifically delete *Lfng* from Lfng-expressing NSCs, we crossed *Lfng*^flox/flox^ mice ([@bib73]) with the *Lfng*-CreER^T2^; RCL-tdT mice. In the resulting conditional knockout mice (i*Lfng*^fl/fl^), the induced NSCs express non-functional mutant Lfng protein because exon 2 of the *Lfng* has been deleted ([@bib73], [@bib74]). These mutant clones can be visualized as they express tdTomato reporter. We then compared the relative number of BrdU^+^ NSCs between *Lfng-*CreER^T2^;RCL-tdT control mice (tdTomato^+^ GFAP^+^ Sox2^+^), i*Lfng*^fl/fl^ wild-type clones (tdTomato^-^ GFAP^+^ Sox2^+^), and i*Lfng*^fl/fl^ mutant clones (tdTomato^+^). Considerably more mutant NSCs were in S-phase than were either wild-type NSC clones or NSCs in control mice ([Figure 5C](#fig5){ref-type="fig"}, right panel). Interestingly, i*Lfng*^fl/fl^ wild-type clones had a similar ratio of BrdU^+^ NSCs as control mice ([Figure 5C](#fig5){ref-type="fig"}, right panel), suggesting that the effect of Lfng in NSCs is cell-autonomous.

These findings from both constitutive and conditional knockout models suggest that in the absence of *Lfng*, many more NSCs divide. This effect persists not only in physiological but also in pathological conditions: when *Lfng*^−/+^ mice were subjected to ECS, they had a significantly higher ratio of BrdU^+^ NSCs than observed in either sham *Lfng*^−/+^ control (N = 3--4, p=0.0178; [Figure 5D](#fig5){ref-type="fig"}) or ECS-treated *Lfng*-eGFP mice ([Figure 2B](#fig2){ref-type="fig"}). Loss of *Lfng* therefore causes NSCs to be more susceptible to both stimulus-independent and stimulus-dependent division. Indeed, Notch signaling, as measured by NICD1 immunofluorescence intensity, was much lower in individual mutant NSC clones in i*Lfng*^fl/fl^ mice two weeks after induction compared to controls ([Figure 5E](#fig5){ref-type="fig"}). This suggests that decreased Notch signaling might contribute to loss of NSC quiescence in *Lfng* mutant NSCs.

Our findings also revealed an interesting phenomenon: the difference in the fold change of Ki67^+^/ BrdU^+^ NSCs in mutant mice (1.21 fold) was lower than the Ki67^+^/ BrdU^+^ NSCs in wild-type mice (1.81 fold). This means that most cycling NSCs are in the S-phase in the mutant mice. To delve deeper into the biology of *Lfng* effect on NSC cell cycle, we used sequential labeling with BrdU analogs, 5-chloro-2-deoxy-uridine (CldU) and 5-iodo-2-deoxy-uridine (IdU) ([@bib13]; [@bib23]; [@bib49]). To define the initial proliferative NSCs cohort, 3-month-old wild-type, *Lfng*^−/+^, i*Lfng*^fl/fl^, and *Lfng-*CreER^T2^; RCL-tdT control mice were injected with CldU. To mark NSCs that pass through the subsequent S-phase(s), we injected IdU 3 or 7 days after CldU. By determining the fraction of CldU/IdU double-labeled NSCs, it is possible to quantify the number of NSCs that re-entered S-phase 3 or 7 days apart ([@bib23]). Many double-labeled NSCs were observed in the wild-type mice, only a few were detected in the *Lfng*^−/+^ mice at either timepoint, but none were found in i*Lfng*^fl/fl^ mice ([Figure 5F](#fig5){ref-type="fig"}). *Lfng* thus not only affects the NSC cell cycle but is also critically important for NSC cell cycle re-entry. Lack of double labeling could be due to intermittent division or to a genuine exit from the cell cycle. As *Lfng*^−/+^ mice had a decreased ratio of CldU/Ki67 double labeled NSCs 7 days following CldU injection (N = 4; p=0.0105; [Figure 5G](#fig5){ref-type="fig"}), these data strongly indicate that *Lfng* mutant NSCs either dilute BrdU by multiple divisions, die, or directly differentiate/ transform into another cell type over the course of seven days.

Thus, we examined the number of NSCs that retained BrdU ([Figure 5H](#fig5){ref-type="fig"}, left panel). In *Lfng* mutant mice, after a two-hour pulse, only 5.2% of the initial BrdU^+^ NSC population retained BrdU after 7 days (N = 4 per timepoint, p=0.0003). In control mice, however, 92.4% of the initial BrdU^+^ NSC population retained BrdU after 7 days (N = 4 per timepoint, p=0.38). Further, we observed fewer NSCs with multiple S-phase re-entry in *Lfng* mutant mice at both 3 and 7 days ([Figure 5F](#fig5){ref-type="fig"}), arguing against BrdU dilution. To then rule out the possibility that NSC depletion is caused by a rise in apoptosis, we turned to the conditional i*Lfng*^fl/fl^ mice and quantified the number of apoptotic cells. Both immunostaining for activated caspase-3 and the ApopTag assay, which detects DNA strand breaks, indicated that i*Lfng*^fl/fl^ actually had fewer apoptotic cells than control ([Figure 5---figure supplement 1A,B](#fig5s1){ref-type="fig"}). Most apoptotic cells in SGZ are ANPs and differentiating neuroblasts, with very few astrocytes or NSCs ([@bib13]; [@bib64]). Notch signaling in *iLfng*^fl/fl^ mice is downregulated ([Figure 5E](#fig5){ref-type="fig"}) and thus more apoptotic cells would be expected ([@bib56]). The surprising decrease in the number of apoptotic cells could thus be due to the production of fewer ANPs in *iLfng*^fl/fl^ mice.

To then determine the fate of the NSCs, we quantified tdTomato^+^ NSCs (Sox2^+^, single radial GFAP^+^ process), ANPs (Sox2^+^, GFAP^-^), and astrocyte-like cells (Sox2^+^, multiple GFAP^+^ processes emerging from the cell body). We observed a declining trend in the number of mutant NSCs (p=0.8215; 0.11; 0.06 for 1, 7, and 30 days, respectively), and a significant decline in the number of mutant ANPs (p=0.2817; 0.0024; 0.0049 for 1, 7, and 30 days, respectively) ([Figure 5H](#fig5){ref-type="fig"}, middle panel). This is not surprising, as *Lfng* removal caused fewer NSCs to undergo multiple rounds of cell cycle, which could impede ANP production. Interestingly, we observed a notable increase in tdTomato^+^ astrocyte-like cells at 7 and 30 days post-induction (p=0.0003 and p\<0.0001, respectively). This warranted further examination to ensure that these cells are the progeny of induced mutant NSCs: we quantified the BrdU-retaining astrocyte-like cells and found a greater number of these cells in *Lfng* mutant mice, but only at 7 days (N = 4 per group, p=0.0302; [Figure 5H](#fig5){ref-type="fig"}, right panel). At 30 days, there was no difference compared to control mice (p=0.4412), suggesting that NSCs lacking *Lfng* differentiate more rapidly into astrocyte-like cells, depleting the NSC population more quickly.

In sum, in the absence of *Lfng*, many more NSCs divide at the population level compared to controls. *Lfng*-deficient NSCs also spend less time in the active state, produce fewer ANPs over time, and tend to differentiate into astrocyte-like cells more rapidly than controls, which depletes the NSC population prematurely. These effects appear to depend on the level of *Lfng*, as homozygous conditional knockout mice had more pronounced alterations.

Notch ligands Jag1 and Dll1 preserve NSCs by opposing effects on their cell cycle {#s2-5}
---------------------------------------------------------------------------------

We then set out to examine the effects of Dll1 or Jag1 loss of function on NSC recruitment, proliferation (cycling and S-phase), cell cycle duration, and generation of their immediate progeny. Our prediction was that lack of Dll1 and Jag1 would have opposing effects on these measures. Mice lacking *Dll1* (*Dll1*^tm1Gos^ (JAX 002957; *Dll1*^−/+^)) ([@bib32]) had far fewer NSCs than wild-type mice or those lacking *Jag1* (*Jag1*^tm1Grid^ (JAX 010616; *Jag1*^−/+^)) ([@bib75]) or *Lfng* ([Figure 6A](#fig6){ref-type="fig"}, [Figure 5B](#fig5){ref-type="fig"}, respectively). This was accompanied by a substantial increase in the ratio of cycling, Ki67^+^ cells and BrdU^+^ NSCs (N = 4 per group; p=0.0007 for Ki67, p\<0.0001 for BrdU experiment; [Figure 6B](#fig6){ref-type="fig"}), suggesting that the dramatic decrease in the NSC population in mice lacking *Dll1* might be due to increased cycling and S-phase entry, as observed in *Lfng*^−/+^ mice. Interestingly, no difference in the amount of NSCs was observed between wild-type and *Jag1*^−/+^ mice (N = 4 per group; p=0.1663; [Figure 6A](#fig6){ref-type="fig"}), but there was an upward trend in the proportion of BrdU^+^ NSCs (N = 4 per group; p=0.8393; [Figure 6B](#fig6){ref-type="fig"}, middle panel). There was, however, a significant increase in Ki67^+^ NSCs lacking *Jag1* (N = 4 per group, p\<0.0001; [Figure 6B](#fig6){ref-type="fig"}, left panel), suggesting that these NSCs may have a prolonged cell cycle. Indeed, the proportion of Ki67^+^/BrdU^+^ NSCs in *Jag1*^−/+^ mice was higher compared to *Dll1*^−/+^ mice (3.97 vs. 1.40 fold).10.7554/eLife.24660.011Figure 6.Notch ligands Jag1 and Dll1 regulate NSC cell cycle.(**A**) The number of NSCs is diminished in mice lacking *Dll1* compared to both wild-type and mice lacking *Jag1* (N = 4 per group; One-way ANOVA p\<0.00001, Tukey HSD post-hoc test p\<0.0001 for *Dll1* vs wild-type or *Jag1*^−/+^, p=0.1663 for wild-type vs *Jag1*^−/+^). (**B**) Lack of either *Dll1* or *Jag1* promotes increased division of NSCs. *Left panel*: Absence of *Dll1* or *Jag1* is associated with significantly higher proportion of cycling, Ki67^+^ NSCs (N = 4 per group, One-way ANOVA p\<0.00001, Tukey HSD post-hoc test p\<0.0001 for wild-type vs *Dll1*^−/+^ or *Jag1*^−/+^, p=0.046 for *Dll1*^−/+^ vs *Jag1*^−/+^). *Middle panel:* Mice lacking *Dll1* have significantly higher proportion of dividing, BrdU^+^ NSCs compared to both wild-type and *Jag1*^−/+^ mice (N = 4 per group; One-way ANOVA p\<0.0005, Tukey HSD post-hoc test p=0.0007 for wild-type vs *Dll1*^−/+^, p=0.0015 for *Jag1*^−/+^ vs *Dll1*^−/+^, p=0.8393 for wild-type vs *Jag1*^−/+^). *Right panel:* Absence of both copies of *Jag1* in i*Jag1*^fl/fl^ mice is associated with significantly higher proportion of actively dividing, BrdU^+^ NSCs compared to controls (N = 4 per group; Student's *t*-test, p=0.0028). (**C**) Lack of *Dll1* has an opposite effect on NSC S-phase re-entry compared to lack of *Jag1*. Relative number of NSCs that re-enter S-phase 3 (*left panel*) and 7 (*middle panel*) days following the initial division is significantly lower in mice lacking *Dll1* at 7 days, while it is significantly higher at both timepoints in mice lacking *Jag1* compared to wild-type mice (for 3d: N = 4 per group; One-way ANOVA p=0.0074, Tukey HSD post-hoc test p=0.9624 for wild-type vs *Dll1*^−/+^, p=0.011 for *Jag1*^−/+^ vs *Dll1*^−/+^, p=0.0164 for wild-type vs *Jag1*^−/+^; for 7d: N = 4 per group; One-way ANOVA p\<0.0001, Tukey HSD post-hoc test p=0.0016 for wild-type vs *Dll1*^−/+^, p\<0.0001 for *Jag1*^−/+^ vs *Dll1*^−/+^, p=0.0002 for wild-type vs *Jag1*^−/+^). CldU^+^ IdU^+^ cells represent NSCs that underwent first division at the time of CldU injection (day 0) and were in S-phase at the time of IdU injection (day 3 or day 7). *Right panel:* In i*Jag1*^fl/fl^ mice, significantly higher proportion of NSCs re-enter S-phase 6 days following the initial division compared to controls (N = 4 per group; Student's *t*-test, p=0.0003). CldU^+^ IdU^+^ cells represent NSCs that were induced at day 0, underwent first division at 1 day post-induction (CldU^+^) and were in S-phase (IdU^+^) at 7 days post-induction. (**D**) Lack of *Dll1* has an opposite effect on NSC cycling time compared to lack of *Jag1* (N = 4 per group; One-way ANOVA p\<0.00001, Tukey HSD post-hoc test p=0.0049 for wild-type vs *Dll1*^−/+^, p=0.005 for wild-type vs *Jag1*^−/+^ and p\<0.0001 for *Dll1*^−/+^ vs *Jag1*^−/+^). CldU^+^ Ki67^+^ NSCs represent NSCs that are cycling 7 days following the CldU injection. (**E**) Lack of *Jag1* increases Notch signal intensity in NSCs. Relative intensities of NICD1 staining are significantly higher in *Jag1* mutant NSC clones compared to control NSCs (N = 3 for i*Jag1*^fl/fl^, N = 4 for control; Student's t-test p\<0.0255). (**F**) In *Dll1*^−/+^ mice, no NSCs that retained BrdU 7 days after the BrdU injection were detected. In *Jag1*^−/+^ mice, the absolute number of BrdU-retaining NSCs is significantly higher at both timepoints compared to wild-type mice, suggesting increased self-renewal of NSCs lacking *Jag1* (For 7d: N = 4 per group; One-way ANOVA p\<0.00001, Tukey HSD post-hoc test p\<0.0001 for wild-type vs *Jag1*^−/+^ and *Jag1*^−/+^ vs *Dll1*^−/+^, and p=0.0035 for wild-type vs *Dll1*^−/+^. For 2hr-7d comparisons: p=0.0028 for *Jag1*^−/+^ and p=0.001 for *Dll1*^−/+^ mice). (**G**) *Left graph:* Mice lacking *Jag1* have significantly more Sox2^+^ ANPs compared to both wild-type and mice lacking *Dll1* (N = 4; One-way ANOVA p\<0.00001; p\<0.00001 for wild-type vs *Jag1*^−/+^ and *Dll1*^−/+^ vs *Jag1*^−/+^; p=0.2828 for wild-type vs *Dll1*^−/+^). *Right graph:* Average size of Ki67^+^ clusters around Ki67^+^ NSCs is larger in *Jag1*^−/+^ mice compared to wild-type and *Dll1*^−/+^ mice (N = 4; One-way ANOVA p\<0.00001; p=0.0001 for wild-type vs *Jag1*^−/+^; p=0.0015 for wild-type vs *Dll1*^−/+^, p\<0.0001 for *Dll1*^−/+^ vs *Jag1*^−/+^). (**H**) One month following BrdU injection, *Dll1*^−/+^ mice have significantly higher ratio of S100β^+^ progeny among newly generated cells compared to wild-type (N = 4; Student's t-test, p=0.016). (**I**) In i*Jag1*^fl/fl^ mice, significantly more tdTomato^+^ NSCs accumulate at 7 and 30 days post-induction compared to controls, suggesting increased self-renewal in *Jag1* mutant NSCs. This is accompanied by increased number of tdTomato^+^ ANPs (N = 4 per group; p=0.0263 and p\<0.0001 for NSCs at 7d and 30d, respectively; p=0.0033 and p=0.069 for ANPs at 7d and 30d, respectively). Please note that all wild-type and control mice presented here are same as in [Figure 5](#fig5){ref-type="fig"}, as the experiments using the knockout lines (*Lfng*^−/+^*, Dll1*^−/+^*, Jag1*^−/+^, i*Lfng*^fl/fl^, i*Jag1*^fl/fl^) were done at the same time. The results are presented in two figures for clarity. Bars represent mean ± SEM\* p\<0.05, \*\*p\<0.001, \*\*\*p\<0.0001. See [Figure 6---figure supplement 1](#fig6s1){ref-type="fig"} for further details.**DOI:** [http://dx.doi.org/10.7554/eLife.24660.011](10.7554/eLife.24660.011)10.7554/eLife.24660.012Figure 6---figure supplement 1.Lack of both *Lfng*^−/+^ and *Jag1*^−/+^ has additive effect on NSCs.(**A**) The number of NSCs in 6 month old *Lfng*^−/+^ (L-/+) and *Lfng*^−/+^; *Jag1*^−/+^ (L-/+;J−/+) mice is significantly lower compared to wild-type mice (N = 3 for *Lfng*^−/+^ and *Lfng*^−/+^; *Jag1*^−/+^ and N = 4 wild-type; One-way ANOVA p\<0.00001, Tukey HSD post-hoc test: p\<0.0001 for wild-type vs *Lfng*^−/+^ and *Lfng*^−/+^; *Jag1*^−/+^; and p=0.6869 for *Lfng*^−/+^ vs *Lfng*^−/+^; *Jag1*^−/+^). (**B**) As in *Lfng*^−/+^ mice, NSCs in *Lfng*^−/+^; *Jag1*^−/+^ mice have higher ratio of actively dividing BrdU^+^ NSCs compared to wild-type mice (N = 3; One-way ANOVA p\<0.0002, Tukey HSD post-hoc test: p=0.0001 for wild-type vs *Lfng^−/+^*, p=0.0003 for wild-type vs *Lfng*^−/+^; *Jag1*^−/+^, p=0.6724 for *Lfng^−/+^* vs *Lfng*^−/+^; *Jag1*^−/+^). (**C**) *Lfng*^−/+^; *Jag1*^−/+^ double knockout mice have significantly higher proportion of NSCs re-entering S-phase 1 week following the initial division compared to wild-type (N = 3; One-way ANOVA p\<0.0001, Tukey HSD post-hoc test: p\<0.00001 for wild-type vs *Lfng*^−/+^; *Jag1*^−/+^ and *Lfng^−/+^* vs *Lfng*^−/+^; *Jag1*^−/+^). Bars represent mean ± SEM. \*\*p\<0.001, \*\*\*p\<0.0001.**DOI:** [http://dx.doi.org/10.7554/eLife.24660.012](10.7554/eLife.24660.012)

To further examine this observation and delete *Jag1* specifically from the *Lfng*-expressing NSCs and their progeny, we then crossed *Jag1*^tm2Grid^ (*Jag1*^fl/fl^; JAX 010618) mice ([@bib38]), in which exon 4 of the *Jag1* is deleted ([@bib38]), with the *Lfng-*CreER^T2^;RCL-tdT line. The induced mutant clones lack *Jag1* and can be visualized by tdTomato. In these conditional homozygous knockout mice (i*Jag1*^fl/fl^), the ratio of BrdU^+^ mutant NSCs was significantly higher than in controls (*Lfng-*CreER^T2^;RCL-tdT; N = 4 per group, p=0.0028; [Figure 6B](#fig6){ref-type="fig"}, right panel). We hypothesized that the difference between constitutive heterozygous knockout (upward trend in BrdU^+^ ratio, [Figure 6B](#fig6){ref-type="fig"}, middle panel), and conditional homozygous knockout mice (significant increase in BrdU^+^ ratio, [Figure 6B](#fig6){ref-type="fig"}, right panel) could be due to Jag1's ability to control cell cycle duration but not the recruitment of NSCs from the quiescent population. We tested this possibility by examining the number of NSCs that were still cycling and/or in S-phase 7 days following their initial division in both *Jag1*^−/+^ and i*Jag1*^fl/fl^ mice.

The number of CldU/IdU double-labeled NSCs in both *Jag1*^−/+^ and i*Jag1*^fl/fl^ mice was notably higher than controls at both 3 and 7 days (N = 4 per group, p=0.0164 at 3d, p=0.0016 at 7d; p=0.0003 for i*Jag1*^fl/fl^ mice; [Figure 6C](#fig6){ref-type="fig"}) and accompanied by a greater proportion of CldU^+^ Ki67^+^ NSCs (N = 4 per group; p=0.005 for wild-type vs *Jag1*^−/+^; [Figure 6D](#fig6){ref-type="fig"}). Assuming a typical NSC cell cycle duration of 24--36 hr ([@bib11], [@bib12]; [@bib23]), these data indicate that absence of *Jag1* causes NSCs to re-enter cell cycle. The increase in NICD1 expression in individual mutant NSC clones in i*Jag1*^fl/fl^ mice two weeks after induction ([Figure 6E](#fig6){ref-type="fig"}) supports this notion, in agreement with the reported conditional overexpression of NICD1, which increases cell cycle re-entry of NSCs ([@bib13]).

Conversely, there was no difference in double-labeled NSCs between *Dll1*^−/+^ and wild-type mice at 3 days, but at 7 days no CldU/IdU double-positive cells could be detected, suggesting that NSCs did not re-enter cell cycle (N = 4 per group, p=0.9624 at 3d, p=0.0016 at 7d; [Figure 6C](#fig6){ref-type="fig"}). These observations were then verified by the CldU^+^ Ki67^+^ NSC analysis in *Dll1*^−/+^ mice (N = 4 per group, p=0.0049; [Figure 6D](#fig6){ref-type="fig"}). Thus, whereas the absence of *Jag1* causes NSCs to re-enter the cell cycle while maintaining their overall number, absence of *Dll1* reduces NSC re-entry and substantially decreases their population.

To then examine the progeny of NSCs, we compared the number of NSCs that retained BrdU (BrdU^+^ Sox2^+^ GFAP^+^ NSCs) in *Dll1*^−/+^ and *Jag1*^−/+^ vs. wild-type mice. In the absence of *Dll1*, none of the BrdU^+^ NSCs two hours following a single BrdU injection retained BrdU at 7 days (N = 4; [Figure 6F](#fig6){ref-type="fig"}). The number of Type 2a ANPs did not differ from controls, even though there was a declining trend accompanied by significantly decreased ANP Ki67^+^ cluster size around the NSCs ([Figure 6G](#fig6){ref-type="fig"}). To determine the fate of NSCs in *Dll1*^−/+^ mice, we injected BrdU and sacrificed the animals 30 days later. We observed significantly more S100β^+^ astrocytes among the BrdU^+^ cells. Thus, as in *Lfng*^−/+^, more *Dll1* mutant NSCs terminally differentiate into astrocytes (N = 4 per group, p=0.016; [Figure 6H](#fig6){ref-type="fig"}).

The findings were opposite in mice lacking *Jag1*: the number of BrdU retaining NSCs was much greater 7 days following the BrdU pulse (1.6 fold, p=0.0028) than two hours after the pulse ([Figure 6F](#fig6){ref-type="fig"}). Thus, NSCs lacking *Jag1* may have undergone self-renewal. We then quantified the total number of tdTomato^+^ NSCs and ANPs in i*Jag1*^fl/fl^ at 1, 7 and 30 days following induction. Initially, both control and mutant mice had a similar number of tdTomato^+^ NSCs and ANPs, but this number markedly increased at both 7 and 30 days in mutant compared to control mice (N = 4 per group, p=0.0263 and p\<0.0001 for NSC at 7d and 30d, p=0.0033 and p=0.069 for ANP at 7d and 30d; [Figure 6I](#fig6){ref-type="fig"}). Interestingly, there was no difference in the number of tdTomato^+^ NSCs between 7 and 30 days (N = 3--4, p=0.3903), whereas the number of tdTomato^+^ ANPs dropped significantly. Removal of *Jag1* therefore might lead to an initial increase in the accumulation of NSCs, previously interpreted as an indicator of self-renewal ([@bib18]). In addition, increased S-phase re-entry, observed in NSCs from both *Jag1*^−/+^ and i*Jag1*^fl/fl^ ([Figure 6C](#fig6){ref-type="fig"}), might also lead to increased production of ANPs. Indeed, both the number of Type 2a ANPs and the size of the ANP clusters were significantly greater in *Jag1*^−/+^ mice than controls (**[Figure 6G](#fig6){ref-type="fig"}).** To determine whether apoptosis had any role in the increased number of ANPs in *Jag1* mutants, we quantified the number of apoptotic cells using activated caspase-3 staining and ApopTag. Both methods demonstrated a prominent decrease in the number of apoptotic cells in *iJag1*^fl/fl^ mice compared to wild-type ([Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}).

Finally, we attempted to generate a double knockout of *Dll1* and *Jag1,* which would provide us with clues about the combinatorial effect of the lack of both ligands in the SGZ NSC niche. Mating the two constitutive lines did not succeed, most likely because of the lack of compensatory mechanisms in these two constitutive mutations during embryogenesis. As our data indicate that lack of *Lfng* or *Dll1* exhibit similar phenotypes with respect to NSC recruitment and cell cycle duration ([Figure 5B,C,F,G](#fig5){ref-type="fig"} and [Figure 6A--D,F](#fig6){ref-type="fig"}), we generated a *Lfng*^−/+^; *Jag1*^−/+^ double heterozygous constitutive knockout line and measured NSC number, short term (2 hr) BrdU incorporation and 1 week cell cycle re-entry (CldU^+^/IdU^+^) in 6 month old mice. *Lfng*^−/+^; *Jag1*^−/+^ double knockout mice had far fewer NSCs than wild-type (N = 3 for Lfng^−/+^; Jag1^−/+^ and N = 4 controls; p\<0.0001 for wild-type vs Lfng^−/+^ and Lfng^−/+^; Jag1^−/+^), but did not differ significantly from *Lfng*^−/+^ mice (N = 3 for Lfng^−/+^, p=0.6869 for Lfng^−/+^ vs Lfng^−/+^; Jag1^−/+^; [Figure 6---figure supplement 1A](#fig6s1){ref-type="fig"}). The double knockout showed a higher BrdU^+^ NSC ratio than wild-type (N = 3; p=0.0001 for wild-type vs Lfng^−/+^, p=0.0003 for wild-type vs Lfng^−/+^; Jag1^−/+^, p=0.6724 for Lfng^−/+^ vs Lfng^−/+^; Jag1^−/+^; [Figure 6---figure supplement 1B](#fig6s1){ref-type="fig"}), similar to *Lfng*^−/+^ mice. This suggests that in both mouse models, the NSC population is exhausted by increased recruitment due to the lack of *Lfng*. Finally, we observed greater NSC cell cycle re-entry in double knockout mice (N = 3; p\<0.00001 for wild-type vs Lfng-/+; Jag1^−/+^ and Lfng^−/+^ vs Lfng^−/+^; Jag1^−/+^), suggesting that removal of *Jag1* can reverse the low cell cycle re-entry phenotype observed in the NSCs lacking *Lfng* ([Figure 6---figure supplement 1C](#fig6s1){ref-type="fig"}). Overall, these data verified that *Lfng* functions primarily in the recruitment of quiescent NSCs, whereas *Jag1* functions in the cycling NSCs.

Altogether, these data indicate that Notch ligands, Dll1 and Jag1, are important regulators of NSC recruitment, cell cycle duration and exit, and generation of NSC progeny. Lack of *Dll1* increases NSC recruitment, leading to overall larger proportion of dividing NSCs compared to controls, and causes dividing NSCs to be active for a shorter period of time ---there is a tendency to produce fewer ANPs and the total number of NSCs falls dramatically following increased terminal astrocytic differentiation. This phenotype thus resembles premature exhaustion of NSCs. On the other hand, lack of *Jag1* does not affect NSC recruitment, as the proportion of dividing NSCs did not differ from controls. Those that were dividing were active for a longer period and had increased cell cycle re-entry, ultimately leading to greater ANP production and increased NSC self-renewal.

Discussion {#s3}
==========

In this paper, we demonstrate that *Lfng*, a known regulator of Notch signaling, is selectively expressed in adult NSCs, where it participates in their preservation by regulating their cycling. In addition, we provide evidence that distinct modes of Notch signaling from NSC derivatives expressing Jag1 and Dll1 ligands, most likely mediated by Lfng, directly affect the NSC cell cycle. The differential effects of NSC progeny on the ancestor cell could be the key for preserving NSCs and thus neurogenesis throughout life.

These data lead us to propose a model in which Notch signaling provides direct communication between the NSC and its descendants, such that the progeny send feedback signals to the mother cell to modify its cell cycle status ([Figure 7](#fig7){ref-type="fig"}). *Lfng* is central to this model, as it enables NSCs to distinguish between Dll1-expressing granule cells and Jag1-expressing ANPs. In the Notch signal-receiving NSC, Lfng glycosylation of the Notch receptor potentiates Notch signaling from Dll1 and attenuates signaling from Jag1: even though Lfng glycosylation of Notch does not affect Jag1 binding, the NICD is not cleaved from the Jag1-Notch complex. Consequently, Notch signaling decreases. In our model, the resting NSC is surrounded by mostly Dll-expressing granule cells. Thus, most Notch receptors are saturated with Dll1, which induces proteolytic cleavage and boosts the release of NICD in the NSC. The NICD is transported to the nucleus, where it activates a set of genes that ultimately maintain the NSC in a quiescent state with the potential to enter cell cycle if needed. Lfng-mediated Dll1-Notch signaling thus keeps majority of the NSCs in the quiescent state, protecting them from random activation and division.10.7554/eLife.24660.013Figure 7.Proposed model for Lfng-mediated regulation of NSC maintenance by progeny.(**A**) In the resting state, Lfng-expressing NSC (green) is surrounded mostly by Delta1 (Dll)-expressing granule cells (GC, grey). Dll1 binds to the Lfng-modified Notch receptor on the NSC, which boosts Dll1-mediated Notch signaling by producing more NICDs and the NSC is kept quiescent but ready to undergo cell cycle if stimulated. Once activated, NSC (red) starts to produce ANPs. The first progeny (Type 2a, small dark yellow cells) do not express Notch ligands and the NSC continues to divide. As ANPs mature into late ANPs (Type 2b, yellow cells), they start to express Jag1. Jag1 binding to the Lfng-modified Notch receptor on the NSC does not generate NICD and thus the Notch signaling strength in the 'mother' NSC decreases. Eventually, the NSC is surrounded by mostly Jag1-expressing ANPs, and it exits active state (green NSC). Thus, in the resting state, the granule cell progeny prevents overt activation of NSCs, while in the active state, the ANP progeny prevents overt division of the NSC. These feedback signaling from the progeny both act to preserve the NSC population and the integrity of the niche. (**B**) The summary of the loss-of-function data, focusing on the number of activated NSCs (red) and the final outcomes of their division. Mice lacking *Lfng* and *Dll1* have similar phenotypes: NSCs are recruited in bulk, they divide less and faster, and eventually lead to depletion of NSC population. In Lfng mutant mice, there is an increased transformation into astrocytes (blue). Mice lacking *Jag1* have the opposite phenotype: while NSCs are activated as in the wild-type, they divide more and longer, and produce large clusters of ANPs as well as self-renew.**DOI:** [http://dx.doi.org/10.7554/eLife.24660.013](10.7554/eLife.24660.013)

Once a NSC is stimulated to divide (active state), it starts to produce ANPs. The first progeny (Type 2a) do not express Notch ligands and the NSC continues to actively divide. As ANPs mature into late ANPs (Type 2b), they start to express Jag1. Jag1 binding to the Lfng-modified Notch on NSC does not generate NICD, so the local accumulation of Jag1-expressing ANP progeny around the mother NSC gradually lowers the levels of NICD within the NSC and decreases Notch signaling, eventually causing NSC to stop dividing because it is surrounded by progeny. This signaling thus preserves both the spatially-enclosed SGZ niche from an overwhelming number of newborn cells and the NSC itself from over-dividing. Note that our model describes preservation of the NSCs in two contexts: in the resting state, Lfng-boosted Dll1-mediated Notch signaling preserves the NSCs at the population level (i.e., prevents global NSC activation to undergo division), while in the context of active division, Jag1-mediated inhibition of Notch signaling preserves the NSC on the single-cell level (prevents its perpetual division). Therefore, Lfng-mediated Notch signaling could be the key for preserving NSCs in both resting and active states.

Our model is supported by our data on the outcomes of *Lfng, Dll1* and *Jag1* loss-of-function with respect to the NSC number, cell cycle properties, NICD1 intensity, and fate. Lack of *Lfng* reduced NICD1 expression in NSCs and induced many more NSCs to divide at the population level; they spend less time in the active state, produce fewer ANPs and tend to differentiate into astrocyte-like cells, eventually depleting the NSC population. Similar observations were made when Notch signaling in NSCs was inhibited by targeting different components of the pathway. Removal of either Notch1 ([@bib2]) or Rbpj-κ ([@bib20]) caused the depletion of NSCs, which was attributed either to a failure of NSC self-renewal ([@bib2]) or to an initial burst in the number of proliferating NSCs followed by their depletion ([@bib20]). The deletion of Rbpj-κ caused a more robust and faster decrease in the NSC population compared to the removal of Notch1, possibly due to different mechanisms of Rbpj-k and Notch1 signaling. Namely, Rbpj-κ is required not only for Notch1-mediated signaling, but also Notch signaling through other receptors ([@bib4]). Thus, deletion of Rbpj-κ might cause a more severe depletion of NSCs as they could not remain quiescent. On the other hand, at least in the subventricular zone Notch1 seems to be required for the actively dividing NSCs but not when they are in the quiescent phase ([@bib7]); thus, deletion of Notch1 affects only a subpopulation of NSCs.

Our data in *Lfng* mutants resemble both models, suggesting that *Lfng* mediates signaling in both quiescent NSCs (similarly to the Rbpj-k) and active NSCs (similarly to Notch1). Both modes of *Lfng*-mediated action led to multiple rounds of NSC division, which, based on the literature, could be followed by either a return to quiescence ([@bib10]; [@bib49]) or a terminal differentiation into astrocyte-like cell ([@bib23]). Removal of *Lfng* both diminishes the intensity of Dll-Notch signaling and augments the production of NICD following Jag-Notch binding ([@bib9]; [@bib45]; [@bib66]; [@bib69]; [@bib76]). The diminished Dll-Notch signaling causes more quiescent NSCs to be recruited; once they start to produce Jag1-expressing ANPs, NSCs lacking *Lfng* will continue to be exposed to Notch signaling, which might lead to gliogenesis ([@bib13]; [@bib15]; [@bib33]; [@bib68]). Notably, we observed a greater number of astrocyte-like cells in *Lfng* mutants, not increased apoptosis. Indeed, the number of apoptotic cells in the *Lfng* mutant mice was diminished, most likely due to production of fewer ANPs.

As the Lfng-modified Notch receptor enables the cell to distinguish between Dll1 and Jag1 ligands to activate differential downstream targets ([@bib16]; [@bib36]; [@bib57]; [@bib59]; [@bib77]), it is not surprising that Dll1 and Jag1 have opposing effects on NSC biology. Absence of *Dll1* caused a greater proportion of NSCs to undergo division and accelerated their exit from the active state, leading to differentiation into astrocytes and premature exhaustion of the NSC population. On the other hand, absence of *Jag1* exerted its effect on the active NSC population rather than the quiescent one. We base this claim on the following: (i) the total NSC populations in *Jag1*^−/+^ and wild-type mice did not differ, so the quiescent NSCs were not exhausted because of increased recruitment; (ii) the two-hour BrdU incorporation rate was slightly greater in NSCs lacking *Jag1* compared to controls. On the other hand, there was a significant increase in the proportion of BrdU^+^ NSCs in i*Jag1*^fl/fl^ mice compared to controls. This may be due to the dosage difference between the homozygous conditional and heterozygous constitutive *Jag1* knockout mice, which might result in an increase in the actively dividing NSC population rather than increased recruitment of NSCs from the quiescent pool. The extended cycling of NSCs agrees with previously reported extended cycling of NSCs that overexpress NICD ([@bib13]); indeed, NICD1 expression is higher in i*Jag1*^fl/fl^ NSCs. Thus, removal of *Jag1* lowers the chance of NSC to stop dividing via sustaining the Notch signaling intensity, which suggests that Jag1 expressed on the ANP progeny is able to send feedback signals to the ancestor NSC and downregulate its Notch signaling. In addition, our data suggest that in the absence of *Jag1*, NSCs undergo self-renewal in addition to producing large amounts of ANPs. Intuitively, more ANPs should give rise to more new neurons, but conditional ablation of *Jag1* has been shown to cause aberrant neuronal lineage formation ([@bib44]); an increase in the number of ANPs should therefore be interpreted cautiously with respect to neurogenesis. Nevertheless, increased self-renewal with no significant rise in neuronal population has been observed in social isolation ([@bib18]). Thus, it will be interesting to further investigate the mechanisms that mediate self-renewal in the future, as these processes might be exploited for targeted manipulation of NSCs.

Altogether, our data represent a substantial advance in our understanding of adult hippocampal neurogenesis, with critical implications for the preservation of adult NSCs. Namely, Lfng in NSCs along with Dll1 and Jag1 ligands in the progeny are an important part of the regulatory machinery that governs NSC maintenance, controlling their recruitment (preventing global activation), division (both the number and the termination of active state) and terminal fate (preventing over-transformation into astrocyte-like cells), both in physiological and pathological states associated with the NSC impairment.

Materials and methods {#s4}
=====================

Animals {#s4-1}
-------

Experiments were performed using the following mice: *Lfng*-eGFP (RRID:[MMRRC_015881-UCD](https://scicrunch.org/resolver/MMRRC_015881-UCD)) mice obtained from GENSAT ([@bib29]). Generation of *Nestin*-GFP (MGI:5523870) and *Nestin*-CFP^nuc^ were described previously ([@bib24]; [@bib53]). *Lfng*-eGFP mice were received as FVB/N-C57BL/6 hybrids and crossed to C57BL/6 mice for at least 10 generations. C57BL/6J (JAX 000664; RRID:[IMSR_JAX:000664](https://scicrunch.org/resolver/IMSR_JAX:000664)), Lfng^Tm1Grid/J^ (*Lfng*^−/+^, *Lfng*^β-Gal\ −/+^, JAX 010619, RRID:[IMSR_JAX:010619](https://scicrunch.org/resolver/IMSR_JAX:010619)) ([@bib78]), AI14 (RCL-tdT) reporter line (JAX 007908; RRID:[IMSR_JAX:007908](https://scicrunch.org/resolver/IMSR_JAX:007908)) ([@bib51]), CBF:H2B-Venus (JAX 020942; RRID:[IMSR_JAX:020942](https://scicrunch.org/resolver/IMSR_JAX:020942)) ([@bib19]), *Jag1*^tm1Grid^ (*Jag1*^−/+^, JAX 010616; RRID:[IMSR_JAX:010616](https://scicrunch.org/resolver/IMSR_JAX:010616)) ([@bib75]) and *Dll1*^tm1Gos^ (*Dll1*^−/+^, JAX 002957; RRID:[IMSR_JAX:002957](https://scicrunch.org/resolver/IMSR_JAX:002957)) ([@bib32]), *Jag1*^tm2Grid^ (*Jag1*^flox/flox^, JAX 010618; RRID:[IMSR_JAX:010618](https://scicrunch.org/resolver/IMSR_JAX:010618)) ([@bib38]) were purchased from The Jackson Laboratory (Bar Harbor, ME). *Lfng*^flox/flox^ ([@bib73]) mouse was a gift from Dr. Egan (Hospital for Sick Children, Toronto, ON), and is available in The Jackson Laboratory (37160-JAX). Mouse studies were approved by the Baylor College of Medicine Institutional Animal Care and Use Committee.

Generation of the *Lfng-*CreER^T2^ mouse {#s4-2}
----------------------------------------

The RP23-270N2 BAC parent plasmid containing the *Lfng* locus was modified by recombinering to insert a CreERT2 sequence in frame at the transcriptional start site. *Lfng-*CreER^T2^ mice were generated by pronuclear injection of the modified BAC construct into fertilized FVB/n embryos. To trace progeny of *Lfng*-expressing cells, the mice were crossed with Ai14 (RCL-tdT) reporter mice ([@bib51]).

Immunohistochemistry {#s4-3}
--------------------

Animals were deeply anesthetized by injection of 4% Avertin per body weight and perfused transcardially with 30 ml of phosphate-buffered saline (PBS) followed by 30 ml of 4% (w/v) ice cold paraformaldehyde (PFA) in PBS. Brains were removed longitudinally; post fixed with 4% PFA for 4 hr at room temperature, and the PFA was then replaced with PBS and the tissue kept at 4°C. Free floating serial sagittal sections of 50 µm thickness were cut using a vibratome. Sections were incubated with blocking and permeabilization solution (0.3% Triton-100X and 3% BSA in PBS) for 2 hr at room temperature, followed by overnight incubation at 4°C with the primary antibody diluted in the same permeabilization-blocking solution. Sections were then washed three times with PBS and incubated with fluorochrome-conjugated secondary antibodies diluted in permeabilization-blocking solution for 2 hr at room temperature. Sections were then washed three times with PBS and mounted on coated slides with DakoCytomation Fluorescent Mounting Medium (DakoCyomation, Carpinteria, CA) as anti-fading agent.

For immunostaining against BrdU, CldU, IdU, and Ki67 sections were treated with 2N HCl for 30 min at 37°C, followed by rinsing with PBS and incubation with 0.1M sodium tetraborate (pH 8.5) for 10 min at room temperature and then again rinsing with PBS. For rabbit anti-Dll1 (Santa Cruz Biotechnology Cat\# sc-9102 RRID:[AB_668782](https://scicrunch.org/resolver/AB_668782)) at 1:100; rabbit anti-Jag1 (Santa Cruz Biotechnology Cat\# sc-8303 RRID:[AB_649685](https://scicrunch.org/resolver/AB_649685)) at 1:100; rabbit anti-Hes5 (Millipore Cat\# AB5708 RRID:[AB_11213867](https://scicrunch.org/resolver/AB_11213867)) at 1:100; rabbit anti-Notch1 (Santa Cruz Biotechnology Cat\# sc-9170 RRID:[AB_650334](https://scicrunch.org/resolver/AB_650334)) at 1:100; rabbit anti-cleaved Notch1 (Assay Biotech Cat\# L0119 RRID:[AB_10687460](https://scicrunch.org/resolver/AB_10687460) at 1:100; sections were pre-treated in 3% hydrogen peroxide solution (Sigma-Aldrich, St. Louis, MO) first at 37°C for 10 min and another 20 min at room temperature. Then sections were boiled in 10 mM citric acid- Tween (0.05%) antigen retrieval solution (pH 6) for 10 min, followed by 0.1M sodium tetraborade (pH 8.5) treatment for 10 min at room temperature. Finally, sections were incubated in permeabilization and blocking solution (1% BSA, 4% horse serum, 0.2% Triton-X) for an hour followed by overnight incubation of primary antibodies at 4°C. Anti-rabbit HRP conjugated pre-absorbed secondary antibodies were used to label these antigens for 2 hr. Finally, Tyramide Signal Amplification (TSA) Cy3 or Cy5 kit (Perkin Elmer, Waltham, MA) kit was used to amplify the signal.

In the experiments where sections were treated with HCl for BrdU, CldU, IdU, and Ki67 detection or with citric acid-based antigen retrieval solution for Dll1, Jag1, Hes5, Notch1, and NICD1 detection, we had to use antibodies against GFP or RFP to detect GFP or tdTomato, as they rapidly fade due to the acidic treatment of the tissue. The eGFP signal from *Lfng*-eGFP and *Nestin*-GFP mice, or tdTomato signal in Ai14 crossed control and conditional knockout mice was amplified with antibodies against GFP (chicken anti-GFP (Aves Labs Cat\# GFP-1020 RRID:[AB_10000240](https://scicrunch.org/resolver/AB_10000240)) at 1:1000), or with antibodies against RFP rabbit anti-RFP (Rockland Cat\# 600-401-379 RRID:[AB_2209751](https://scicrunch.org/resolver/AB_2209751)) at 1:500); goat anti-RFP (SICGEN, Cantanhede, PORTUGAL) at 1:200). Anti-GFP or anti-RFP antibodies were not used for other analyses.

For other antigens, the following antibodies were used: chicken anti-beta galactosidase (Abcam Cat\# ab9361 RRID:[AB_307210](https://scicrunch.org/resolver/AB_307210)) at 1:1000; mouse anti-BrdU (Bio-Rad / AbD Serotec Cat\# OBT0030CX RRID:[AB_609566](https://scicrunch.org/resolver/AB_609566)) (also used for detecting CldU) at 1:300; rat anti-BrdU (Becton Dickinson and Company Cat\# 347580 RRID:[AB_10015219](https://scicrunch.org/resolver/AB_10015219)) (also used to detect IdU); rat anti CD31 (BD Biosciences Cat\# 550274 RRID:[AB_393571](https://scicrunch.org/resolver/AB_393571)) at 1:500; goat anti-Dcx (Santa Cruz Biotechnology Cat\# sc-8066 RRID:[AB_2088494](https://scicrunch.org/resolver/AB_2088494)) at 1:200; rabbit anti-Dcx (Cell Signaling Technology Cat\# 4604S RRID:[AB_10693771](https://scicrunch.org/resolver/AB_10693771)) at 1:200; mouse anti-GFAP (Sigma-Aldrich Cat\# G3893 RRID:[AB_477010](https://scicrunch.org/resolver/AB_477010)) at 1:1000; rabbit anti-GFAP (Dako Cat\# Z0334 RRID:[AB_10013382](https://scicrunch.org/resolver/AB_10013382)) at 1:1000 rabbit anti-Ki67 (Vector Laboratories Cat\# VP-RM04 RRID:[AB_2336545](https://scicrunch.org/resolver/AB_2336545)) at 1:300; mouse anti-Nestin (Abcam Cat\# ab6142 RRID:[AB_305313](https://scicrunch.org/resolver/AB_305313)) at 1:500; mouse anti-NeuN (Millipore Cat\# MAB377 RRID:[AB_2298772](https://scicrunch.org/resolver/AB_2298772)) at 1:500; mouse anti-PSA-NCAM (Millipore Cat\# MAB5324 RRID:[AB_11210572](https://scicrunch.org/resolver/AB_11210572)) at 1:400; rabbit anti-S100β (Dako Cat\# Z0311 RRID:[AB_10013383](https://scicrunch.org/resolver/AB_10013383)) at 1:300; rabbit anti-Sox2 (Abcam Cat\# ab97959 RRID:[AB_2341193](https://scicrunch.org/resolver/AB_2341193)) at 1:500; Rabbit anti-Tbr2 (Abcam Cat\# ab23345 RRID:[AB_778267](https://scicrunch.org/resolver/AB_778267)) at 1:000; mouse anti-Vimentin (Dako Cat\# M7020 RRID:[AB_2304493](https://scicrunch.org/resolver/AB_2304493)) at 1:300; secondary antibodies (conjugated with Alexa 488, 594, or 657) (all pre-absorbed against other species to prevent cross reactivity) (Jacskon Immunoresearch, West Grove, PA) at 1:500. Sections were counterstained with DAPI (5 μg/mL, Sigma) at 1:1000.

Confocal microscopy and stereology {#s4-4}
----------------------------------

To estimate the total number of different cell types or cells that are positive for different antigens without falling into a spatial bias, 50 μm free-floating sagittal sections spanning through the whole dentate gyrus were collected in five parallel sets using vibratome. Each set contained 13--14 sections 250 μm apart from each other. Previously described modified optical dissector method ([@bib22]) was used for unbiased quantification of absolute number of different cell types in the whole brain. Briefly, an observer blind to experimental groups counted immunoreactive cells that had the aforementioned markers and morphological properties in every fifth sagittal section throughout the dentate gyrus. NSCs were identified as cells with triangular cell body in the SGZ, a GFAP^+^ radial process originating from a Sox2^+^ nuclei in SGZ and spanning through granule cell layer in mice without the fluorescence reporter (C57BL/6, *Lfng*^−/+^, *Jag1*^−/+^, *Dll1*^−/+^, tdTomato^-^ clones in i*Lfng*^fl/fl^, i*Jag1*^fl/fl^, and *Lfng-*CreER^T2^; RCL-tdT control mice). In mice with a fluorescence reporter (*Lfng*-eGFP, *Nestin*-GFP, and tdTomato^+^ clones in i*Lfng*^fl/fl^, i*Jag1*^fl/fl^, and *Lfng-*CreER^T2^; RCL-tdT control mice), a triangular cell body located in the SGZ and a terminal ending with fine arborizations in granule cell layer-molecular layer boundary was also included as the criteria for NSC identification. Type2a and Type2b cells were identified as GFAP^-^ Dcx^-^ Sox2^+^ or Tbr2^+^, respectively, round cells in the SGZ without a process cells. Neuroblasts and immature neurons were identified as Dcx^+^ cells with single or multiple processes. Granule cells were identified as NeuN^+^ cells with prominent dendritic arborizations. Astrocytes were identified as S100β^+^ cells with stellar morphology. Astrocyte-like cells in i*Lfng*^fl/fl^ mice were identified GFAP^+^ S100β^-^ cells with stellar morphology and multiple processes.

For quantification that required analysis of the phenotypic morphology and/or overlap of multiple markers (including BrdU, CldU, IdU, and Ki67), 20 µm thick optical sections were scanned with confocal microscope (Leica SP5, Leica SP8 or a Zeiss LSM 710). Three-dimensional reconstructions and orthogonal views were obtained using Zen 2012 SP1 software (Zeiss, Thornwood, NY) or LAS AF Lite (Leica Microsystems, Buffalo Grove, IL). Cells that were located in the uppermost focal plane were excluded from the quantification to avoid overestimation. Total counts from 13 to 14 sections were multiplied by five for the total number of cells of interest in one hemisphere and then by two to get the total number of cells for both dentate gyri. The proportion of BrdU, CldU, IdU, and Ki67 positive cells among a certain cell type was calculated by dividing the total number of positive cells to previously calculated number of total cells of a particular genotype or to the total number of tdTomato^+^ clones of a particular cell type in lineage analysis.

Clusters were defined as groups of Ki67^+^ cells located around the NSC, where individual cells were separated by 20 µm from their nearest neighbor. Cells beyond this limit were counted as separate clusters. Clusters were counted in every fifth section of the dentate gyrus.

Quantification of NICD1 signal {#s4-5}
------------------------------

Following NICD1 immunofluorescence staining, multiple sections from each genotype were imaged (N = 3 for 2 weeks post TMX injection in i*Jag1*^fl/fl^ and N = 4 for control and i*Lfng*^fl/fl^ mice). 5 µm thick Z-stacks images from both CA1 region and a viewpoint that covers the whole SGZ region of the section were scanned with 2048 × 2048 pixel resolution (Zeiss710 LSM confocal microscope). Maximum intensity projections were converted to Tiff images in ZEN 2012 SP1-black edition 64 bit (Zeiss, Thornwood, NY). Regions of interest for individual NSCs (at least 20 cells per section) were drawn around in the tdTomato^+^ NSC cell body located in the SGZ. Regions of interest in the whole SGZ were drawn as 15 µm thick stripes covering the whole SGZ in the section. To compensate the section-to-section differences due to staining irregularities, NICD1 immunofluorescence intensity of neurons in CA1 region (where *Lfng*-CreERT2 is not active) was used as control (75 µm X 50 µm rectangle). Blue channel fluorescence intensities (corresponding to Cy5 signal in TSA amplified NICD1 immunostaining) were measured by Histo tool in ZEN lite 2012-blue edition and intensities were normalized according to CA1 measurements.

Quantification of venus/NICD1 signal overlap {#s4-6}
--------------------------------------------

Following NICD1 immunofluorescence staining, two different sections from CBF:H2b-Venus animals (N = 3) were imaged. 15 µm thick Z-stacks images with 2048x2048 pixel resolution were scanned with Zeiss710 LSM confocal microscope. At least 200 cells were counted from SGZ and GZ of each section to evaluate the overlap between Venus and NICD1 signals in the same cell.

Detection of apoptotic cells {#s4-7}
----------------------------

For activated caspase-3 staining, paraffin embedded sections (8 µm thick) from control, i*Lfng*^fl/fl^, and i*Jag1*^fl/fl^ animals two weeks post TMX injection were treated with antigen retrieval solution (Tris-EDTA pH 9.0), followed by primary antibody treatment (anti act-casp3 antibody; Abcam, Cambridge, MA) and DAB staining (Abcam, Cambridge, MA) according to manufacturer's protocol. Due to high yield clearance of apoptotic cells from SGZ ([@bib1]; [@bib47]; [@bib64]), we also used ApopTag Peroxidase in situ apoptosis detection kit (EMD Millipore, Billerica, MA). Bright field images were acquired by Zeiss Axio Imager M2 microscope and the total number of apoptotic cells located in 30 µm of SGZ was counted.

Electroconvulsive shock (ECS) and voluntary physical exercise {#s4-8}
-------------------------------------------------------------

ECS experiments were performed using Ugo Basile 57800 Unit (Varese-Italy). Bilateral ECS was administered via moistened pads on ear clips using pulse generator in 3-month-old male *Lfng*-eGFP mice (N = 4, frequency, 50 Hz, shock duration 0.5 s, pulse width 0.5msec, current 50mA) at the same time each day for four consecutive days. BrdU (150 mg/kg) was injected at the fourth day, 2 hr after the last ECS treatment. Sham animals were exposed to the same procedure but did not receive a shock. Mice were sacrificed 24 hr following the BrdU injection and brains were processed for immunostaining with anti-BrdU antibody, as described above.

For voluntary physical exercise, two animals were placed in a cage (3 cages in total, N = 6) with a running wheel and their physical activity was monitored by Actimetrics system (Wilmette, IL) for a week. Control animals were housed in the same type of cage but with a locked running wheel. BrdU (150 mg/kg) was injected at the seventh day. Mice were sacrificed 24 hr later and brains were processed for immunostaining with anti-BrdU antibody, as described above.

Temozolomide, tamoxifen, DTX, BrdU, CldU, and IdU injections {#s4-9}
------------------------------------------------------------

Temozolomide (Sigma-Aldrich, St. Louis, MO, 25 mg/kg in DMSO, PBS) was administered as four intraperitoneal injections. Control mice were injected with a vehicle. Four hours after the last injection, the mice were perfused transcardially and processed as described above. Diphtheria Toxin from Corynebacterium diphtheriae (Sigma-Aldrich, St. Louis, MO, 16 µg/kg in PBS) was administered as four intraperitoneal injections. Tamoxifen (200 mg suspended in 10 ml of 1:9 ethanol:corn oil mixture) solution was administered either at high (200 mg/kg) or low (120 mg/kg) dose. Control mice were injected with ethanol:corn oil mixture only. BrdU (150 mg/kg) was administered as described in schemes of the corresponding figures. CldU (85 mg/kg) and IdU (115 mg/kg) were administered in equimolar concentrations. BrdU and CldU were dissolved in sterile saline. IdU was dissolved in sterile saline solution that contained 2% of 0.2N NaOH.

Statistics {#s4-10}
----------

Statistical analysis was performed using GraphPad Prism 7.0 (GraphPad RRID:[SCR_002798](https://scicrunch.org/resolver/SCR_002798)). The sample size was determined based on our previous publications ([@bib64], [@bib65]) and published data from other groups. Experiments involving two groups were compared using un-paired Student t-test. Experiments involving more than two groups with one variable were compared by One-Way Analysis of Variance (ANOVA), followed by Tukey HSD post-hoc test analysis for pairwise comparisons. Types of test were indicated in the figure legends. Exact p values were indicated in the main text next to sample size. Significance was defined as p\<0.05. Data are shown as mean± SEM \*p\<0.05, \*\*p\<0.001, \*\*\*p\<0.0001 denoted the corresponding significance levels in all graphs.
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In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

\[Editors' note: a previous version of this study was rejected after peer review, but the authors submitted for reconsideration. The first decision letter after peer review is shown below.\]

Thank you for choosing to send your work entitled \"Hippocampal neural stem cells selectively express lunatic fringe\" for consideration at *eLife*. Your full submission has been evaluated by a Senior Editor a Reviewing Editor and three peer reviewers, and the decision was reached after discussions between the reviewers. We regret to inform you that your work will not be considered further for publication.

There are a number of major issues raised by your reviewers and the editors handling your manuscript, but two key issues stand out: 1) the lack of lineage tracing of Lfng^+^ cells to demonstrate that these marked cells give rise to neurons in vivo and 2) the lack of substantial mechanistic insights as to how Lfng affects neurogenesis of hippocampal stem cells. As such, although the expression patterns of Lfng^+^ are provocative and this will no doubt be of interest to stem cell biologists, the critical evidence necessary to make a case for *eLife* is missing. Although the decision of *eLife* is not to publish, you may want to consider in revising your submission elsewhere that two of your reviewers found the writing difficult to read and confusing in parts.

*Reviewer \#1:*

In this study the authors characterize the expression of Lunatic Fringe (Lfng) as a neural stem cells (NSCs) marker. In particular, they create a new transgenic mouse strain harboring the GFP under the control of the Lfng promoter and compare the Lfng-GFP expression with another well-established NSC reporter Nestin-GFP. They claim that, compared to Nestin-GFP, Lfng is a more specific marker for the quiescent NSC typeI. They phenotypically characterized the Lfng positive cells for other NSCs markers and demonstrate that Lfng is specifically expressed in the quiescent NSCs, being loss in the transition to amplifying neural progenitors (ANP) and derivatives. Moreover, by crossing the Lfng reporter with a Lfng knockout mouse they demonstrate that Lfng has an important role in the NSCs biology by preserving the NSCs population by restraining their proliferation. The general purpose of the study seems to be the creation and validation of a new NSCs marker useful for further studies. However, the authors present here some data about the specific role of this gene in the physiology and behavior of the NSCs.

The authors identified and counted different cell types such as NSCs and ANPs based only on cell morphology. This is an imperfect assay to discriminate the two population, the authors should include markers analysis such as Tbr2 for ANPs.

The in vitro characterization of Lfng-GFP cells should be improved. The authors isolate the GFP positive cells from Lfng-GFP mice and place them in neurosphere culture. The neurospheres lost the expression of the GFP and the authors claim that this is because the neurospheres are populated with progenitors. The authors must substantiate this claim with specific markers. Moreover, the Lfng-derived neurospheres should be analyzed for other stem cells marker expression, self-renewal and differentiation capacity. A full demonstration that these cells are NSCs is central and still needed.

In the BrdU assay described in [Figure 5I](#fig5){ref-type="fig"} is unclear how the authors determined and counted the different cell subpopulation.

The authors argue that Lfng has a role in the stem cells pool maintenance by regulating stem cells quiescence. But, at face value (see Figure.7D-E), the data show that, 1) endogenous LNFR is required to inhibits proliferation as measured by BrdU (at least on this putative NCS population above identified); 2) to promote proliferation as measured by Ki67 (in absolute terms); 3) to sustain NSC, that decline in the KOs (a data perhaps at odd with point 1); iii) to promotes differentiation. They comment that "elevated proportion of proliferating NSCs in Lfng^-/+^ mice did not lead to increased number of INs, as one may expect. Rather, the total number of INs highly correlated with the absolute number of NSCs (R=0.9948) and not the total number of proliferating NSCs." (before Discussion).

I find this very confusing. And the following conclusion is, in my opinion, a stretched interpretation of a complex set of data: ..."Together, these data indicate that loss of Lfng causes impaired NSC maintenance due to increased proliferation rates of NSCs, which over time result in decreased number of newborn cells and the phenotype indicative of premature exhaustion of neurogenesis."...

The authors never considered other interpretations, such as cell death (by various means), transition to different cell types other than those here studied. At the very least the conclusion should be changed.

*Reviewer \#2:*

In this manuscript, Semerci et al. reported the identification of Lunatic Fringe (Lfng) as an adult hippocampal neural stem cell (NSC) marker. The authors carefully characterized Lfng-eGFP cells, and compared and contrasted them with Nestin-eGFP cells. Furthermore, the authors took advantage of Lfng knockout mice to demonstrate that Lfng is required to maintain adult hippocampal NSCs. The logic of the study is clear and straightforward. The data is convincing.

I have the following comments:

1\) The study focused on adult hippocampal NSCs. In [Figure 1---figure supplement 1H](#fig1s1){ref-type="fig"}, the authors showed that Lfng-eGFP cells are present in SVZ. It is unclear whether Lfng plays a similar role in other adult NSCs, i.e. SVZ NSCs. The author should clarify this.

2\) In [Figure 2](#fig2){ref-type="fig"}, the authors presented the evidence that Lfng-eGFP is expressed selectively in NSCs. It would be important to provide quantitative analysis for these experiments. Does Lfng-eGFP label all NSCs or a subpopulation? In addition, it appears that Lfng-eGFP cells include both NSCs with a triangular shape cell body and a radial process and ANPs with horizontal processes ([Figure 2G](#fig2){ref-type="fig"}). Based on the examples shown in [Figure 2I, J](#fig2){ref-type="fig"}, the authors concluded that the eGFP+ ANPs are newborn with residual eGFP. How representative are these examples? In [Figure 2H](#fig2){ref-type="fig"}, it appears the vast majority of Nestin-CFP cells express some Lfng-eGFP.

3\) Related to the previous comment, how does Lfng-eGFP compare with Hes5-eGFP, which preferentially labels a subset of NSCs and ANPs? The authors may want to discuss about this.

4\) In the Abstract, the authors wrote \"NSCs are dispensable.\" Does this mean for viability?

5\) It is somewhat confusing who made Lfng-eGFPTg mice, authors or GENSAT? In the main text of the manuscript, it says that the authors made the mice, but in the Materials and methods it says that it was from GENSAT.

6\) In [Figure 5C](#fig5){ref-type="fig"}, it is hard to see any neurospheres. A better image should be provided.

*Reviewer \#3:*

This paper proposes to have identified a new marker (lunatic fringe -- Lfng) for neural stem cells in the sub granular zone of the dentate gyrus. While localization and morphology place Lfng in the right place at the right time and evidence is provided that Lfng cells can divide, critical evidence that their progeny give rise to neurons is lacking. In general, the paper is poorly written and there is virtually no information on the mechanism by which Lfng might affect neurogenesis of hippocampal stem cells.

The so-called bioinformatics approach does not involve any new datasets. Rather the authors simply queried published gene expression databases such as Allen and GENSAT, which provides detailed gene expression data at cellular resolution. The data in [Figure 1](#fig1){ref-type="fig"} (supplemental?) are not publishable as they are available on the Gensat website.

There are many crucial experiments lacking in this paper, most notably a genetic lineage trace to show that Lfng positive cells give rise to neurons. What is provided is that Lfng^+^ cells can divide (BrdU) and that cells that have undergone division (BrdU^+^) can give rise to neurons. Another issue that is not addressed is the timing of expression of Lfng^+^ cells -- the authors only show the timing of EGFP, which is likely very different than the timing of LFNG, given the perdurance of EGFP. The neurosphere experiments are concerning for many reasons, there is no indication of the efficiency of purification and since the Egfp transgene is not expressed, it is not valid to count the number of BrdU labeled cells and assumed they express Lfng. There is no measurement of Lfng RNA and protein in the crosses between the Gensat line and the loss of function hets. The identification of cell types is poorly controlled. Finally, there are no experiments to provide insight as to the mechanism of action, if any, of Lfng in adult hippocampal neurogenesis.

\[Editors' note: what now follows is the decision letter after the authors submitted for further consideration.\]

Thank you for resubmitting your work entitled \"Lunatic fringe-mediated Notch signaling regulates adult hippocampal neural stem cell maintenance\" for further consideration at *eLife*. Your revised article has been favorably evaluated by a Senior Editor, a Reviewing Editor, and three reviewers.

The manuscript has been improved but there are a few remaining issues that need to be addressed before acceptance, as outlined below:

Reviewer \#2 suggests a few revisions to the figures and then one simple staining. Reviewer 3 has some concerns regarding your interpretations, and these seem reasonable. We\'d thus ask you to adjust the text accordingly. In addition, like reviewer 2, this reviewer asks for more stainings and demonstration that you can reliably identify Notch signal activation (reliability of Hes5 staining, NICD staining, and Notch reporter in the tissues) and also confirm the specificity of Dll1 and Jag1 antibodies (staining patterns in your knockout animals) and demonstrate which cells are high for Notch signaling and which cells are negative for Notch signaling. Similar Notch signaling analysis in your inducible Lfng knockout animals seems reasonable.

The stainings should not take long for you to do, but they will go a long way in validating your findings. The revisions will also be useful both for your and our readers.

*Reviewer \#1:*

The manuscript by Maletic-Savatic et al. is remarkably improved. It now provides elegant evidence that lunatic fringe is a new marker for Hippocampal NSCs and that Lfng along with the Notch ligands Jag1 and/or Δ functions in regulating cell cycle and generation of neurons from NSCs. In its revised form, this manuscript is an important advance on our understanding of mechanisms underlying adult neurogenesis in the hippocampus. I have no substantial concerns with the revised manuscript.

*Reviewer \#2:*

In this revised manuscript, Semerci et al. have made an impressive effort in extending and improving their original study. In particular, they generated a new mouse line (i.e. Lfng-CreERT2) allowing a systematic in vivo lineage tracing of LFNG-expressing cells (i.e. neural stem cells, NSCs) in the adult hippocampus. Moreover, they carried out comprehensive genetic analyses to explore potential mechanisms underlying the function of LFNG in NSC maintenance. In addition, the authors improved the characterization of cell types and NSC behavior, as well as the comparison between the Lfng-GFP and Nestin-GFP lines.

The revised manuscript is greatly improved and the authors have addressed my previous concerns.

*Reviewer \#3:*

Semerci et al. investigate the function of Lunatic Fringe (Lfng) in maintaining the hippocampal NSCs. Lfng is a known component in the Notch pathway. By generating two Lfng lines: Lfng-EGFP and Lfng-CreER, the authors conducted comprehensive analysis of Lfng expression in the hippocampus. With lineage-tracing and ablation, they demonstrated that Lfng marks largely the hippocampal NSCs. To investigate the function of Lfng in NSCs, they further knockout Lfng in NSCs, and compared the results with knockout of Notch ligand Dll1 and Jag1.

Overall, the results are comprehensive and interesting, and the topic is of great interest to the broad readership of *eLife*. The analyses related to Lfng expression and lineage tracing are rigorous. This said, I have some concerns regarding the authors\' interpretation of Lfng, Dll1, and Jag1 phenotypes. Below I listed some questions that should be addressed before publication.

1\) The analyses regarding Jag1 and Dll1 are incomplete and the conclusions are quite forced. First of all, using straight knockout to analyze adult phenotypes often complicate the interpretation due to accumulated effects since embryonic stage. The fact that Jag1^+/-^ and inducible knockout of Jag1 have different phenotypes illustrates this point. Before more cell-type specific Jag1/Dll1 mutants are generated, these data are suggestive at best. Second, it is difficult to assess from the presented image whether Notch signaling is indeed up-regulated in the NSCs: It is unclear if NICD is on the Lfng-eGFP NSCs in the represented picture, the Hes5 staining looks like punta rather than nuclear, and CBF-H2B-Venus looks positive in the majority of the cells that are *Sox2* negative (and only in one cell that is *Sox2* positive). How specific and reliable are these antibodies as readouts of Notch signaling? The authors should do the following to strengthen this part of the data since these data are closely related to whether daughter cells indeed send feedback to stem cells via Notch signaling, one of the key conclusions of the paper:

a\) Demonstrate that they can reliably identify Notch signal activation (reliability of Hes5 staining, NICD staining, and Notch reporter in the tissues they are working with) and also confirm the specificity of Dll1 and Jag1 antibodies (for example, they can examine the staining patterns in their knockout animals). Perform rigorous analysis (and quantifications) to demonstrate which cells are high for Notch signaling and which cells are negative for Notch signaling.

b\) Perform similar Notch signaling analysis in their inducible Lfng knockout animals, so that they can directly compare Lfng wild type and knockout NSCs and their downstream progeny and demonstrate unequivocally that Notch signal is indeed affected in the Lfng knockout NSCs (and not other cell types).

c\) Explain the discrepancies between Jag^+/-^ and inducible Jag1 knockout data.

d\) Significantly revise and tone down their claims about Notch signaling and the action of Notch ligand Dll1 and Jag1 unless they can demonstrate knockout data that is more cell type specific.

2\) The authors\' interpretation for their BrdU, or CIdU/IdU phenotype in Lfng mutant and Dll1/Jag1 is confusing and difficult to understand. Some textual changes will be essential to make these data more accessible to the readers.

Specifically, their data suggest that in Lfng mutant, (i) label retaining NSCs decrease with time (which is not due to multiple rounds of cell cycle entry during the chase period since fewer NSCs enter S phase twice in Lfng mutant); (ii) label retaining astrocytes increase with time; (iii) more NSCs are proliferating at any given time; and (iv) NSCs numbers are reduced. If apoptosis status is not altered in Lfng mutants (see below), this data together with the lineage-tracing data suggest that upon loss of Lfng, more NSCs are in cycle at any given time, but there is a shift in the division outcomes with regard to what cells are produced. In wild type, many of these divisions generate ANPs and stem cells, while in Lfng knockout animals, more astrocytes are produced.

The authors\' statements like \"NSCs lacking Lfng mostly exited the cell cycle\", \"Lfng removal caused NSCs to exit cycling mode earlier\", or \"these data indicate that absence of Jag1 causes NSCs to be in cell cycle for a prolonged length of time, while absence of Dll1 causes them to exit cell cycle\" are confusing, and send out the opposite message. \"NSCs exit cell cycle\" implies that \"NSCs are withdrawn from the cell cycle and become quiescent but remain as NSCs\". If this is the phenotype, they should have observed more BrdU label-retaining NSCs, not less. A more appropriate statement might be \"NSCs differentiate into astrocytes\". In all, the authors should modify all of these related statements to convey the results more truthfully and enhance the readability of their manuscript.

3\) The authors should also conduct apoptosis analysis to determine if changes in cell numbers are due to abnormal apoptosis, which is an independent mechanism that will influence interpretation.

4\) The authors should provide evidence suggesting that Lfng-CreER is not active without tamoxifen induction (i.e., no leakage issue that might confound the interpretation).

10.7554/eLife.24660.016

Author response

\[Editors' note: the author responses to the first round of peer review follow.\]

*Reviewer \#1:*

*\[...\] The authors identified and counted different cell types such as NSCs and ANPs based only on cell morphology. This is an imperfect assay to discriminate the two population, the authors should include markers analysis such as Tbr2 for ANPs.*

We agree that cell morphology is imperfect; we have now done extensive quantifications based on the expression of previously known markers of these cells. First, we have established that markers known to label NSCs, such as nestin, *Sox2*, vimentin and GFAP, were all expressed in *Lfng*(BAC)::eGFP+ cells ([Figure 1D](#fig1){ref-type="fig"}). ANPs were discriminated from NSCs based not only on their round morphology but also the presence of *Sox2* and Tbr2 and lack of markers such as GFAP and Dcx. We distinguished early ANPs (Type 2a: round cells in the SGZ that express *Sox2* and lack GFAP and Dcx) from late ANPs (Type 2b: round cells in the SGZ that express Tbr2) ([Figure 1E](#fig1){ref-type="fig"}). We then continued to use these markers to quantify NSCs and ANPs in most other experiments throughout the paper.

To demonstrate the specificity of Lfng expression to NSCs, we performed a series of additional experiments. Using the *Lfng*(BAC)::eGFP/*Nestin*-CFP^nuc^ double transgenic mice and immunostaining with markers listed above, we detected only 7% (7.41 ± 1.95%; N=3) ANPs that were eGFP+. Next, we showed that *Lfng*(BAC)::eGFP is expressed only in minority of Type2a ANPs (*Sox2* + GFAP- cells in the SGZ; 10.58 ± 2.38, N=3), unlike *Nestin*-GFP (94.7 ± 0.34, N=4). We then determined the clearance time of the eGFP signal from Type 2a ANPs, using BrdU pulse-and-chase labeling. eGFP was cleared between days 1 and 3 ([Figure 1F](#fig1){ref-type="fig"} left graph), which correlates with the eGFP half-life. Finally, using temozolomide to kill dividing cells, we quantified NSCs and ANPs and demonstrated that Lfng-expressing NSCs were mostly quiescent ([Figure 2A](#fig2){ref-type="fig"}). Together, these data strongly suggest that most of the *Lfng*(BAC)::eGFP+ cells are NSCs. The *Lfng*(BAC)::eGFP+ ANPs are the immediate progeny of NSCs that retained some eGFP due to sequestration of the protein during cell division. ANPs quickly lose eGFP, implying that *Lfng*(BAC)::eGFP expression is selective for NSCs and that *Lfng* is active in NSCs but not in ANPs.

*The in vitro characterization of Lfng-GFP cells should be improved. The authors isolate the GFP positive cells from Lfng-GFP mice and place them in neurosphere culture. The neurospheres lost the expression of the GFP and the authors claim that this is because the neurospheres are populated with progenitors. The authors must substantiate this claim with specific markers. Moreover, the Lfng-derived neurospheres should be analyzed for other stem cells marker expression, self-renewal and differentiation capacity. A full demonstration that these cells are NSCs is central and still needed.*

We have now generated the lineage tracing mouse and effectively demonstrated the multipotentiality of Lfng expressing cells in vivo ([Figure 3](#fig3){ref-type="fig"} and [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}). Therefore, we have removed the in vitro data from the revised paper.

*In the BrdU assay described in [Figure 5I](#fig5){ref-type="fig"} is unclear how the authors determined and counted the different cell subpopulation.*

[Figure 5I](#fig5){ref-type="fig"} in the initial submission is now [Figure 2C](#fig2){ref-type="fig"}, and the quantification of the cells is described in detail in the Materials and methods section. For each time point in each genotype (*Nestin*-GFP and *Lfng*-eGFP), we performed three sets of immunostainings from each animal (n=4 per time point). We used: 1) mouse anti-GFAP, rabbit anti-*Sox2* and rat anti-BrdU for the first set; 2) rabbit anti-Dcx, mouse anti-NeuN, and rat anti-BrdU for the second; and 3) mouse anti-GFAP, rabbit antiDcx, and rat anti-BrdU for the third. NSCs were identified as BrdU^+^ cells with a *Sox2Sox2*^+^ nuclei and triangular soma in the SGZ, from which a single GFAP+ radial process extended orthogonally and spanned the granule cell layer, ending in fine arborizations within the molecular layer. These cells lacked all other markers. ANPs were identified as BrdU^+^ round GFAP- Dcx-cells in the SGZ. Immature neurons-neuroblasts and granule cells were Dcx+ and NeuN+, respectively. Cells outside of the SGZ and negative for Dcx and NeuN were categorized as \'other\'.

To estimate the total number of different cell types or cells that are positive for different antigens without falling into a spatial bias, 50μm free-floating sagittal sections spanning through the whole dentate gyrus were collected in 5 parallel sets using a vibratome. Each set contained 13-14 sections 250μm apart from each other. The previously described modified optical dissector method (Encinas and Enikolopov, 2008) was used for unbiased quantification of absolute number of different cell types in the whole brain. Briefly, an observer blind to experimental groups counted immunoreactive cells that had the aforementioned markers and morphological properties in every fifth sagittal section throughout the dentate gyrus. Cells that were located in the uppermost focal plane were excluded from the quantification to avoid overestimation. Total counts from 13-14 sections were multiplied by 5 for the total number of cells of interest in one hemisphere and then by 2 to get the total number of cells for both dentate gyri.

*The authors argue that Lfng has a role in the stem cells pool maintenance by regulating stem cells quiescence. But, at face value (see [Figure 7D-E](#fig7){ref-type="fig"}), the data show that, 1) endogenous LNFR is required to inhibits proliferation as measured by BrdU (at least on this putative NCS population above identified); 2) to promote proliferation as measured by Ki67 (in absolute terms); 3) to sustain NSC, that decline in the KOs (a data perhaps at odd with point 1); iii) to promotes differentiation. They comment that "elevated proportion of proliferating NSCs in Lfng^-/+^ mice did not lead to increased number of INs, as one may expect. Rather, the total number of INs highly correlated with the absolute number of NSCs (R=0.9948) and not the total number of proliferating NSCs." (before Discussion).*

*I find this very confusing. And the following conclusion is, in my opinion, a stretched interpretation of a complex set of data: "Together, these data indicate that loss of Lfng causes impaired NSC maintenance due to increased proliferation rates of NSCs, which over time result in decreased number of newborn cells and the phenotype indicative of premature exhaustion of neurogenesis."*

*The authors never considered other interpretations, such as cell death (by various means), transition to different cell types other than those here studied. At the very least the conclusion should be changed.*

In the initial paper, we showed that in the constitutive *Lfng* knockout mice, there is increased recruitment of NSCs and thus an increased ratio of both BrdU^+^ and Ki67+ NSCs. We concluded that lack of *Lfng* impairs NSC maintenance by initially increasing the rate of proliferation, which prematurely exhausts the NSC population and thus the ultimate number of newborn neurons. We agree with the reviewer that further proof was warranted.

In the revised paper, we provide additional data using both constitutive and conditional knockout mice, in which we specifically deleted *Lfng* from Lfng-expressing NSCs ([Figure 4](#fig4){ref-type="fig"}). In sum, those data demonstrate that in the absence of Lfng, many more NSCs divide at the population level compared to controls. Lfng-deficient NSCs spend less time in the active state, produce fewer ANPs over time, and have a tendency to differentiate into astrocyte-like cells more rapidly than controls, which depletes the NSC population prematurely. These effects appear to depend on the level of Lfng, as homozygous conditional knockout mice had more pronounced alterations.

*Reviewer \#2:*

*\[...\] I have the following comments:*

*1) The study focused on adult hippocampal NSCs. In [Figure 1---figure supplement 1H](#fig1s1){ref-type="fig"}, the authors showed that Lfng-eGFP cells are present in SVZ. It is unclear whether Lfng plays a similar role in other adult NSCs, i.e. SVZ NSCs. The author should clarify this.*

In both the initial paper and the revised manuscript, we characterize *Lfng*-eGFP NSCs in the SGZ only. We plan to characterize Lfng expression and function in SVZ niche in a future study.

*2) In [Figure 2](#fig2){ref-type="fig"}, the authors presented the evidence that Lfng-eGFP is expressed selectively in NSCs. It would be important to provide quantitative analysis for these experiments. Does Lfng-eGFP label all NSCs or a subpopulation? In addition, it appears that Lfng-eGFP cells include both NSCs with a triangular shape cell body and a radial process and ANPs with horizontal processes ([Figure 2G](#fig2){ref-type="fig"}). Based on the examples shown in [Figure 2I, J](#fig2){ref-type="fig"}, the authors concluded that the eGFP+ ANPs are newborn with residual eGFP. How representative are these examples? In [Figure 2H](#fig2){ref-type="fig"}, it appears the vast majority of Nestin-CFP cells express some Lfng-eGFP.*

Please see the answer to Reviewer \#1, first comment, for an outline of the methodology used to quantify and distinguish NSCs and ANPs. In the revised manuscript, we have performed additional experiments to address the reviewers' questions.

A nearly complete overlap between *Lfng*-eGFP expression and Nestin ([Figure 1D](#fig1){ref-type="fig"}) indicates that Lfng expressing NSCs are mostly the same population of NSCs labeled by *Nestin*-GFP. We corroborated this finding by comparing the total number of NSCs in *Nestin*-GFP and *Lfng*-eGFP mice at distinct time points throughout life ([Figure 2D](#fig2){ref-type="fig"}). In addition, 84% of the *Lfng*-eGFP+ cells were also GFAP+ ([Figure 1D](#fig1){ref-type="fig"}). As nearly all GFAP+ radial processes that originate from SGZ and end at the border between the granule cell and molecular layers were also *Lfng*-eGFP+, it is plausible that Lfng is expressed in the same population of NSCs that are labeled with *GFAP*GFP. Nevertheless, NSCs are very heterogeneous and there are differences in the labeling efficiencies depending on the transgenic mouse line (Giachino and Taylor, 2014; Semerci and Maletic-Savatic, 2016). Thus, we cannot rule out the possibility that *Lfng*-eGFP labels in part a different population of cells in comparison to other mouse models. We have done extensive work to demonstrate its specificity to NSCs and will pursue characterization of sub-populations of *Lfng*-eGFP+ NSCs in the future.

*3) Related to the previous comment, how does Lfng-eGFP compare with Hes5-eGFP, which preferentially labels a subset of NSCs and ANPs? The authors may want to discuss about this.*

To determine whether active Notch signaling is present in the *Lfng*-eGFP NSCs, we performed immunostaining against cleaved intracellular domain of Notch1 (NICD1) and Hes5 ([Figure 5A](#fig5){ref-type="fig"}), as well as used the Notch reporter mouse, CBF-H2B-Venus (Duncan et al., 2005). These experiments all verified that only a subset of NSCs have active Notch signaling, indicating a similar pattern observed in *Hes5*-eGFP mice (Basak and Taylor, 2007; Lugert et al., 2012). Lack of NICD1 and Hes5 in many *Lfng*-eGFP+ NSCs suggests that Lfng expression is not limited to the cells with active Notch signaling but rather extends to a broader population.

*4) In the Abstract, the authors wrote \"NSCs are dispensable.\" Does this mean for viability?*

In the revised manuscript, we eliminated this confusing statement and instead state that NSCs have different fates, ranging from terminal astrocytic differentiation to self-renewal.

*5) It is somewhat confusing who made Lfng-eGFPTg mice, authors or GENSAT? In the main text of the manuscript, it says that the authors made the mice, but in the Materials and methods it says that it was from GENSAT.*

We thank the reviewer for noticing the ambiguity. In the revised paper, we made it clear that we purchased the *Lfng*-eGFP mice from GENSAT as FVB/N- C57BL/6 hybrid. We then crossed it to C57BL/6 mice for at least 10 generations before starting the characterization of the *Lfng*-eGFP expression in the SGZ.

*6) In [Figure 5C](#fig5){ref-type="fig"}, it is hard to see any neurospheres. A better image should be provided.*

In the revised manuscript, we excluded the in vitro studies in favor of our newer in vivo evidence of the *Lfng*-eGFP NSC multipotentiality, from the lineage tracing mouse ([Figure 3](#fig3){ref-type="fig"} and [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}).

*Reviewer \#3:*

*This paper proposes to have identified a new marker (lunatic fringe -- Lfng) for neural stem cells in the sub granular zone of the dentate gyrus. While localization and morphology place Lfng in the right place at the right time and evidence is provided that Lfng cells can divide, critical evidence that their progeny give rise to neurons is lacking.*

We have now generated a lineage tracing mouse and provide in vivo evidence that Lfng expressing cells are multipotent stem cells, able to self-renew and give rise to both neurons and astrocytes ([Figure 3](#fig3){ref-type="fig"} and [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}).

*In general, the paper is poorly written and there is virtually no information on the mechanism by which Lfng might affect neurogenesis of hippocampal stem cells.*

We have extensively revised the paper and conducted new experiments that provide new evidence on the role of Lfng in NSCs ([Figure 4](#fig4){ref-type="fig"}). Further, we also provide new data on Notch ligands, Jag1 and Dll1, and their effects on NSC cell cycle and fate ([Figure 5](#fig5){ref-type="fig"}). We also worked with a native English speaker to improve the clarity of the writing, and we hope the manuscript is now easier to read.

*The so-called bioinformatics approach does not involve any new datasets. Rather the authors simply queried published gene expression databases such as Allen and GENSAT, which provides detailed gene expression data at cellular resolution. The data in [Figure 1](#fig1){ref-type="fig"} (supplemental?) are not publishable as they are available on the Gensat website.*

In the revised paper, we explain our database query in the Introduction, as this query has led us to hypothesize that Lfng is a selective marker of NSCs. We removed the expression data from other brain regions; please note that in the initial paper these data were not taken from the GENSAT database but were produced from our own experiments. The fact that they matched GENSAT expression data reassured us that back-crossing to C57/Bl6 mice did not affect the Lfng expression pattern.

*There are many crucial experiments lacking in this paper, most notably a genetic lineage trace to show that Lfng positive cells give rise to neurons. What is provided is that Lfng^+^ cells can divide (BrdU) and that cells that have undergone division (BrdU^+^) can give rise to neurons.*

We have now generated a lineage tracing mouse and provided the in vivo evidence that Lfng expressing cells are multipotent stem cells, able to self-renew and give rise to both neurons and astrocytes ([Figure 3](#fig3){ref-type="fig"} and [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}).

*Another issue that is not addressed is the timing of expression of Lfng^+^ cells -- the authors only show the timing of EGFP, which is likely very different than the timing of LFNG, given the perdurance of EGFP.*

The reviewer raises an important issue: how much *Lfng*-eGFP expression correlates with Lfng protein expression? First, Lfng has been shown to have an oscillatory expression pattern in other systems (Kageyama et al., 2007; Maroto et al., 2005; Okubo et al., 2012). We don\'t know if it oscillates in NSCs. This would be important if Lfng is expressed in only a subset of NSCs and not in the whole NSC population. In this case, *Lfng*-eGFP would partially label the NSC population and thus, the total number of labeled cell would be significantly different from the total number of NSCs in other mouse models, such as *Nestin*-GFP. However, our data showed that almost all *Lfng*-eGFP+ cells express Nestin ([Figure 1D](#fig1){ref-type="fig"}) and further, that *Lfng*-eGFP and *Nestin*-GFP mice have similar numbers of NSCs throughout their lifetime ([Figure 2D](#fig2){ref-type="fig"}). These data suggest that Lfng expression is stable enough to drive the expression of eGFP in all NSCs labeled by Nestin. Other eGFP reporter lines such as *Hes5*-eGFP (Basak and Taylor, 2007; Lugert et al., 2012) that are based on Hes5 promoter with an oscillatory expression pattern, label only a subset of NSCs in which Hes5 is present.

Second, eGFP might stay in cells longer than Lfng protein. To determine the eGFP clearance from the labeled cells, we have performed additional experiments that demonstrate that eGFP is completely lost from the cells between day 1 and day 3 ([Figure 1E](#fig1){ref-type="fig"} left graph). Thus, even if Lfng has an oscillatory expression pattern, it is shorter than the life of eGFP.

Finally, our knockout experiments, both constitutive and conditional, indicate that Lfng expression is important not only for a part of NSC life, but for both quiescent and active NSCs ([Figure 4](#fig4){ref-type="fig"}).

*The neurosphere experiments are concerning for many reasons, there is no indication of the efficiency of purification and since the Egfp transgene is not expressed, it is not valid to count the number of BrdU labeled cells and assumed they express Lfng.*

Please see the answer to reviewer \#1, second comment.

*There is no measurement of Lfng RNA and protein in the crosses between the Gensat line and the loss of function hets.*

Both the constitutive and conditional Lfng knockout mice have been used in previous studies where Lfng protein levels and the RNA have been determined (Benedito et al., 2009; Xu et al., 2010; Xu et al., 2012; Zhang and Gridley, 1998). We have thus not performed these experiments.

*The identification of cell types is poorly controlled.*

In the revised paper, we have done extensive quantifications based not only on the morphology of cells but also on the expression of previously known markers of these cells, as described in detail in the methods section. Please also see the answer to reviewer \#1, first comment above.

*Finally, there are no experiments to provide insight as to the mechanism of action, if any, of Lfng in adult hippocampal neurogenesis.*

We have extensively revised the paper and conducted new experiments that provide new evidence on the role of Lfng in NSCs ([Figure 4](#fig4){ref-type="fig"}). Further, we also provide new data on Notch ligands, Jag1 and Dll1, and their effects on NSC cell cycle and fate ([Figure 5](#fig5){ref-type="fig"}). These data suggest the Lfng is a key modulator of NSC cell cycle and fate.

\[Editors\' note: the author responses to the re-review follow.\]

*Reviewer \#3:*

*\[...\] Overall, the results are comprehensive and interesting, and the topic is of great interest to the broad readership of eLife. The analyses related to Lfng expression and lineage tracing are rigorous. This said, I have some concerns regarding the authors\' interpretation of Lfng, Dll1, and Jag1 phenotypes. Below I listed some questions that should be addressed before publication.*

*1) The analyses regarding Jag1 and Dll1 are incomplete and the conclusions are quite forced. First of all, using straight knockout to analyze adult phenotypes often complicate the interpretation due to accumulated effects since embryonic stage. The fact that Jag1^+/-^ and inducible knockout of Jag1 have different phenotypes illustrates this point. Before more cell-type specific Jag1/Dll1 mutants are generated, these data are suggestive at best. Second, it is difficult to assess from the presented image whether Notch signaling is indeed up-regulated in the NSCs: It is unclear if NICD is on the Lfng-eGFP NSCs in the represented picture, the Hes5 staining looks like punta rather than nuclear, and CBF-H2B-Venus looks positive in the majority of the cells that are Sox2 negative (and only in one cell that is Sox2 positive). How specific and reliable are these antibodies as readouts of Notch signaling? The authors should do the following to strengthen this part of the data since these data are closely related to whether daughter cells indeed send feedback to stem cells via Notch signaling, one of the key conclusions of the paper:*

*a) Demonstrate that they can reliably identify Notch signal activation (reliability of Hes5 staining, NICD staining, and Notch reporter in the tissues they are working with) and also confirm the specificity of Dll1 and Jag1 antibodies (for example, they can examine the staining patterns in their knockout animals). Perform rigorous analysis (and quantifications) to demonstrate which cells are high for Notch signaling and which cells are negative for Notch signaling.*

We thank the reviewer for pointing out the discrepancy between CBF-H2B-Venus signal and NICD staining, which motivated us to search for a new antibody and optimize the protocol.

In our initial submission, we used CBF-H2F-Venus mice to demonstrate Notch activity in NSCs ([Figure 4B](#fig4){ref-type="fig"} -- upper right panel). Both reviewer 2 and reviewer 3 urged us to complement these data with more detailed examination of Notch signaling through NICD staining, particularly in mutant mice.

To directly assess the presence and intensity of Notch signaling, we first need a reliable method to detect Notch signaling strength. Although CBF:H2B-Venus mice are a good tool to evaluate the presence or absence of Notch signaling, the accumulation of Venus fluorescence protein and high fluorescence intensity in the GZ (please see [Figure 4B](#fig4){ref-type="fig"}) make it hard to perform reliable intensity quantifications in the SGZ where NSCs reside. We therefore turned to NICD1 as a more reliable measure of Notch signaling intensity.

To verify the reliability of NICD1 staining, we reasoned that NICD1 should be present in cells expressing Venus. Thus, we first stained CBF-H2B-Venus sections with four commercially available NICD1 antibodies (Abcam, cat\#: 8925; Cell Signaling, cat\#: 24215 and 4147S; and Assay Biotech, cat\#L0119), optimized the staining protocol, and quantified the overlap between NICD1 staining and Venus. We found that rabbit anti-NICD1 from Assay BioTech, CA (cat\#L0119) is the best available antibody in the market to show over 90% (90.79% ± 0.77%) signal overlap with CBF-H2B-Venus in SGZ and over 95% (96.95% ± 0.57%) in GZ ([Figure 4C](#fig4){ref-type="fig"} --left insetandright graph). Notably, NICD1 staining was mostly absent in the molecular layer and present in almost all of cells in which Venus was also present ([Figure 4C](#fig4){ref-type="fig"} -- right inset). We then quantified the fluorescence intensity of NICD1 staining in both *iLfng*^fl/fl^ and *iJag1*^fl/fl^ mutant NSC clones ([Figure 5E](#fig5){ref-type="fig"}; [Figure 6E](#fig6){ref-type="fig"}). To normalize the intensity between different sections and samples, we chose NICD1 staining intensity in CA1 neurons of the hippocampus as the control, as there was no *Lfng*-driven CreERT2 activity in these cells. In *Lfng* mutant NSC clones, we expected to see a decrease in Notch signaling as Lfng potentiates Dll1-mediated Notch signals. Indeed, in *iLfng*^fl/fl^ mice, we observed a significant drop in Notch signaling intensity, suggesting that decrease in Notch signaling might contribute to loss of NSC quiescence in *Lfng* mutant NSCs ([Figure 5C, E](#fig5){ref-type="fig"}). In *Jag1* mutant NSC clones, we expected to see an increase in Notch signaling, due to the removal of inhibitory effect of Jag1 on Lfng- modified Notch receptor. Sure enough, we detected a significant increase in Notch signaling intensity in NSCs of *Jag1* mutant mice, which might contribute to extended cycling of these cells ([Figure 6C, E](#fig6){ref-type="fig"}). Since our *Dll1* knockout mouse model is constitutive and has uniform Dll1 expression, we do not have a control region to normalize between samples. Thus, we could not examine the NICD1 signal intensity in *Dll1*^-/+^ mice.

We present these data in Results (subsections "Notch pathway elements are present in the SGZ NSC niche", "Lfng preserves NSCs by controlling their cell cycle" and "Notch ligands Jag1 and Dll1 preserve NSCs by opposing effects on their cell cycle") and describe the methodology in Materials and Methods (subsection "Confocal microscopy and stereology").

We performed a panel of stainings in the CBF-H2B-Venus mice to examine which cells have Notch signaling in the SGZ and GZ of dentate gyrus ([Figure 4B](#fig4){ref-type="fig"}). As reviewer \#3 points out, Venus signal as well as NICD1 staining was mostly localized to GZ, where *Sox2*^-^ cells reside ([Figure 4B, C](#fig4){ref-type="fig"}). Notch signaling plays an important role in the maintenance of granule neurons (Zhuang et al., 2015); thus, granule cells are expected to be positive for both NICD (Brandt et al., 2010; Breunig et al., 2007) and CBF-H2B-Venus signal. Indeed, CBF-H2B-Venus signal overlapped almost completely with NeuN staining with various degrees of intensity ([Figure 4B](#fig4){ref-type="fig"}). However, most Dcx^+^ cells were devoid of Venus signal ([Figure 4B](#fig4){ref-type="fig"}) and only quarter of S100β^+^ astrocytes were positive for Venus ([Figure 4B](#fig4){ref-type="fig"}). We agree with reviewer \#3 that some of the *Sox2Sox2*^+^ cells are negative for CBF-H2B-Venus signal, suggesting that some of the progenitor cells are devoid of active Notch signaling. However, as shown in [Figure 4A](#fig4){ref-type="fig"} -- right panel, B(arrow heads), some of the NSCs are positive for Notch signal. This is in agreement with findings from Breunig and colleagues, who showed that only some of the NSCs have nuclear NICD staining (Breunig et al., 2007). Quantification of Venus^+^ cells among different cell types revealed that cells with active Notch signaling progressively decline from NSCs to immature neurons. Once the cells become mature granule neurons, Notch signaling is turned on again ([Figure 4B](#fig4){ref-type="fig"}). These data are presented in Results (subsection "Notch pathway elements are present in the SGZ NSC niche") and the methodology in Materials and methods. Hes5 is shuttled between nucleus and cytoplasm to control its transcriptional activity (Gottle et al., 2015; Meliou et al., 2011); thus, cytoplasmic staining pattern is possible. Our staining protocol included usage of Tyramide Signal Amplification kit, which might have contributed to the punctuated staining pattern. To demonstrate the specificity of the signal, we have provided new images in the revised manuscript, which includes the GZ ([Figure 4A](#fig4){ref-type="fig"} -- right panel). Due to specific localization of the signal along the GFAP+ process of NSCs in SGZ and absence of it from the GZ, we believe the staining pattern is genuine.

Finally, to demonstrate the reliability of Jag1 antibody, we stained sections from both wild type and i*Jag1*^fl/fl^ mice. Since CreERT2 is driven by *Lfng* promoter in i*Jag1*^fl/fl^ mice, the effect of *Jag1* deletion is expected to be restricted to SGZ and not other parts of the dentate gyrus. This gave us the advantage of a positive control in the conditional knockout tissue. Indeed, in i*Jag1*^fl/fl^ mice, we detected Jag1 staining in the hilar cells while the SGZ was mostly devoid of signal. In wild-type mice, we detected Jag1^+^ cell clusters in the SGZ and hilus, confirming the specificity of Jag1 staining (see [Author response image 1](#fig8){ref-type="fig"}; scale bars=20µm). Finally, the specificity of the Dll1 antibody could not be verified since we have used Dll1 heterozygous constitutive knockout mice.10.7554/eLife.24660.014Author response image 1.Jag1 signal is mostly eliminated from SGZ in i*Jag1*^fl/fl^ mice.Immunostaining for Jag1 expression using anti-Jag1 antibody (Santa Cruz Biotechnology, Santa Cruz, CA) shows that the signal is localized to both SGZ and hilus in control (Ctrl) samples, whereas it is present mostly in hilus in the conditional knockout mice and not in the SGZ. Method is described in Materials and methods section. Scale bar=20µm.**DOI:** [http://dx.doi.org/10.7554/eLife.24660.014](10.7554/eLife.24660.014)

*b) Perform similar Notch signaling analysis in their inducible Lfng knockout animals, so that they can directly compare Lfng wild type and knockout NSCs and their downstream progeny and demonstrate unequivocally that Notch signal is indeed affected in the Lfng knockout NSCs (and not other cell types).*

Please see the answer to reviewer 3, question 1a.

*c) Explain the discrepancies between Jag^+/-^ and inducible Jag1 knockout data.*

We can understand how the difference between the BrdU^+^ NSC ratios in the constitutive and conditional *Jag1* knockout mice might appear confusing. In constitutive heterozygous *Jag1* mice, we find no significant difference in BrdU^+^ NSCs ratio between mutant and wild-type mice, *but there is an upward trend*. In conditional homozygous *Jag1* mice, we find significantly increased BrdU^+^ NSCs ratio compared to control mice. This difference could be due to Jag1's ability to either control cell cycle duration or the recruitment of NSCs from the quiescent population. As we stated in the original text, multiple observations considered together favor the first hypothesis and support the role of *Jag1* in regulation of the NSC cell cycle duration but not in recruitment of quiescent NSCs.

First, if *Jag1* had a role in the recruitment of NSCs, there should be significant difference between the BrdU^+^ NSC ratios of *Jag1*^-/+^ and wild-type mice, but this is not the case ([Figure 6B](#fig6){ref-type="fig"} middle panel, p=0.8393).

Second, increased recruitment should have a negative effect on NSC population in *Jag1*^-/+^ animals as in *Dll1*^-/+^, but there is no significant difference between wild-type and *Jag1*^-/+^ NSC populations ([Figure 6A](#fig6){ref-type="fig"}).

Third, 6 month-old *Lfng*^-/+^ and double constitutive heterozygous knockout *Lfng*^-/+^; *Jag1*^-/+^ mice both have the same number of NSCs ([Figure 6---figure supplement 1A](#fig6s1){ref-type="fig"}) and similar BrdU^+^ NSC ratio ([Figure 6---figure supplement 1B](#fig6s1){ref-type="fig"}), suggesting that *Jag1* does not have an additional effect on the recruitment of NSCs. There was an increased NSC cell cycle re-entry after 1 week BrdU pulse ([Figure 6---figure supplement 1C](#fig6s1){ref-type="fig"}), most likely contributed by indicating that in the double knockout, lack of *Lfng* and lack of *Jag1* have independent effects.

In sum, these data support the hypothesis that the difference between constitutive heterozygous (upward trend in BrdU^+^ ratio) and conditional homozygous (significant increase in BrdU^+^ ratio) *Jag1* knockout data derives from the accumulation of actively cycling NSCs rather than an increase in the recruitment of quiescent NSCs. The increase in NICD1 expression in individual mutant NSC clones in i*Jag1*^fl/fl^ mice two weeks after induction ([Figure 6E](#fig6){ref-type="fig"}) supports this notion, in agreement with the reported conditional overexpression of NICD1, which increases cell cycle re-entry of NSCs (Breunig et al., 2007). To clarify our findings, we modified the text in the Results section (subsection "Notch ligands Jag1 and Dll1 preserve NSCs by opposing effects on their cell cycle") and added to Discussion (sixth paragraph).

*d) Significantly revise and tone down their claims about Notch signaling and the action of Notch ligand Dll1 and Jag1 unless they can demonstrate knockout data that is more cell type specific.*

We have developed a reliable protocol for NICD1 staining to examine Notch signaling in NSCs and their progeny, and independently verified the reliability of the NICD1 staining in CBF:H2B-Venus mice, demonstrating that it overlaps more than 90% in the SGZ NSC niche. We have also shown that conditional removal of *Lfng* from NSCs results in decreased NICD1 intensity, whereas conditional removal of *Jag1* caused a significant increase in the NICD1 intensity in NSCs as well as in SGZ. Thus, in our opinion, we demonstrated that Notch signaling changes in *Lfng* and *Jag1* knockout mice specifically in NSCs. Nevertheless, we modified the text in the Results (subsections "Lfng preserves NSCs by controlling their cell cycle" and "Notch ligands Jag1 and Dll1 preserve NSCs by opposing effects on their cell cycle") and Discussion to clarify our claims.

*2) The authors\' interpretation for their BrdU, or CIdU/IdU phenotype in Lfng mutant and Dll1/Jag1 is confusing and difficult to understand. Some textual changes will be essential to make these data more accessible to the readers.*

*Specifically, their data suggest that in Lfng mutant, (i) label retaining NSCs decrease with time (which is not due to multiple rounds of cell cycle entry during the chase period since fewer NSCs enter S phase twice in Lfng mutant); (ii) label retaining astrocytes increase with time; (iii) more NSCs are proliferating at any given time; and (iv) NSCs numbers are reduced. If apoptosis status is not altered in Lfng mutants (see below), this data together with the lineage-tracing data suggest that upon loss of Lfng, more NSCs are in cycle at any given time, but there is a shift in the division outcomes with regard to what cells are produced. In wild type, many of these divisions generate ANPs and stem cells, while in Lfng knockout animals, more astrocytes are produced.*

*The authors\' statements like \"NSCs lacking Lfng mostly exited the cell cycle\", \"Lfng removal caused NSCs to exit cycling mode earlier\", or \"these data indicate that absence of Jag1 causes NSCs to be in cell cycle for a prolonged length of time, while absence of Dll1 causes them to exit cell cycle\" are confusing, and send out the opposite message. \"NSCs exit cell cycle\" implies that \"NSCs are withdrawn from the cell cycle and become quiescent but remain as NSCs\". If this is the phenotype, they should have observed more BrdU label-retaining NSCs, not less. A more appropriate statement might be \"NSCs differentiate into astrocytes\". In all, the authors should modify all of these related statements to convey the results more truthfully and enhance the readability of their manuscript.*

We have edited the text to the best of our ability. We also performed the 30-day BrdU pulse-and-chase experiment in the *Dll1*^-/+^ mice and showed that more proliferating NSCs terminally differentiate into astrocytes ([Figure 6H](#fig6){ref-type="fig"}). We present these data in Results and Discussion.

*3) The authors should also conduct apoptosis analysis to determine if changes in cell numbers are due to abnormal apoptosis, which is an independent mechanism that will influence interpretation.*

Due to the rapid clearance of apoptotic cells in the SGZ (Sierra et al., 2010), quantification of apoptosis is difficult to examine. We therefore performed apoptosis analysis with two methods to ensure our observations are valid: activated caspase-3 staining and ApopTag®, which detects double-strand DNA breaks. Both methods demonstrated a significant decrease in the number of apoptotic cells in both *iJag1*^fl/fl^ and *iLfng*^fl/fl^ animals compared to wild-type mice ([Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}). In *iJag1*^fl/fl^, although increased production of ANPs was expected to result in a greater number of apoptotic cells, we actually observed significantly fewer apoptotic cells. In *iLfng*^fl/fl^ animals, Notch signaling is downregulated, so more apoptotic cells would be expected. However, we observed a significant decrease in the number of apoptotic cells ([Figure 5---figure supplement 1B](#fig5s1){ref-type="fig"}), most likely due to the production of fewer ANPs in *iLfng*^fl/fl^ mice. We present these findings in Results, subsections "Lfng preserves NSCs by controlling their cell cycle" and "Notch ligands Jag1 and Dll1 preserve NSCs by opposing effects on their cell cycle", and describe the methodology in Materials and methods.

*4) The authors should provide evidence suggesting that Lfng-CreER is not active without tamoxifen induction (i.e., no leakage issue that might confound the interpretation).*

We have added the control experiment (vehicle injection) for tamoxifen induction and no leakage was observed ([Figure 3---figure supplement 1A](#fig3s1){ref-type="fig"}).
